KR20050092421A - 치환된 헤테로시클릭 화합물 - Google Patents
치환된 헤테로시클릭 화합물 Download PDFInfo
- Publication number
- KR20050092421A KR20050092421A KR1020057013173A KR20057013173A KR20050092421A KR 20050092421 A KR20050092421 A KR 20050092421A KR 1020057013173 A KR1020057013173 A KR 1020057013173A KR 20057013173 A KR20057013173 A KR 20057013173A KR 20050092421 A KR20050092421 A KR 20050092421A
- Authority
- KR
- South Korea
- Prior art keywords
- methyl
- yloxy
- propan
- piperazinyl
- methylbenzothiazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001420 substituted heterocyclic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 327
- 201000010099 disease Diseases 0.000 claims abstract description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 15
- 206010002383 Angina Pectoris Diseases 0.000 claims abstract description 12
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 9
- 208000024172 Cardiovascular disease Diseases 0.000 claims abstract description 8
- 241000124008 Mammalia Species 0.000 claims abstract description 8
- 208000010125 myocardial infarction Diseases 0.000 claims abstract description 6
- 206010003130 Arrhythmia supraventricular Diseases 0.000 claims abstract description 5
- 206010007559 Cardiac failure congestive Diseases 0.000 claims abstract description 5
- 206010022562 Intermittent claudication Diseases 0.000 claims abstract description 5
- 206010047281 Ventricular arrhythmia Diseases 0.000 claims abstract description 5
- 208000021156 intermittent vascular claudication Diseases 0.000 claims abstract description 5
- 208000007718 Stable Angina Diseases 0.000 claims abstract description 4
- 206010002388 Angina unstable Diseases 0.000 claims abstract 2
- 208000007814 Unstable Angina Diseases 0.000 claims abstract 2
- 201000004332 intermediate coronary syndrome Diseases 0.000 claims abstract 2
- -1 2-methylbenzothiazol-5-yl Chemical group 0.000 claims description 225
- 125000000217 alkyl group Chemical group 0.000 claims description 73
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 69
- 125000003118 aryl group Chemical group 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 52
- 125000001072 heteroaryl group Chemical group 0.000 claims description 51
- 239000001257 hydrogen Substances 0.000 claims description 48
- 229910052739 hydrogen Inorganic materials 0.000 claims description 48
- 125000004193 piperazinyl group Chemical group 0.000 claims description 46
- 229910052760 oxygen Inorganic materials 0.000 claims description 38
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 37
- 239000001301 oxygen Substances 0.000 claims description 37
- 150000002431 hydrogen Chemical class 0.000 claims description 30
- 125000003545 alkoxy group Chemical group 0.000 claims description 29
- 229910052736 halogen Inorganic materials 0.000 claims description 28
- 150000002367 halogens Chemical class 0.000 claims description 28
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 25
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 24
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 21
- 125000004432 carbon atom Chemical group C* 0.000 claims description 20
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 19
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 18
- 125000002947 alkylene group Chemical group 0.000 claims description 14
- BBVIDBNAYOIXOE-UHFFFAOYSA-N 1,2,4-oxadiazole Chemical group C=1N=CON=1 BBVIDBNAYOIXOE-UHFFFAOYSA-N 0.000 claims description 13
- HECYZXSVAWURCF-UHFFFAOYSA-N 1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound CC(O)COC1=CC=C2SC(C)=NC2=C1 HECYZXSVAWURCF-UHFFFAOYSA-N 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 10
- TUYCYESPUCOVGB-HTAPYJJXSA-N (2r)-1-[(2s)-4-[[5-(4-chlorophenyl)-1,2-oxazol-3-yl]methyl]-2-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(=NO1)C=C1C1=CC=C(Cl)C=C1 TUYCYESPUCOVGB-HTAPYJJXSA-N 0.000 claims description 9
- 125000003107 substituted aryl group Chemical group 0.000 claims description 9
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 9
- 125000002950 monocyclic group Chemical group 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- JAEIVXBXBAMXQD-FXAWDEMLSA-N (2r)-1-[(2s)-4-[[5-(2-chlorophenyl)-1,2-oxazol-3-yl]methyl]-2-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(=NO1)C=C1C1=CC=CC=C1Cl JAEIVXBXBAMXQD-FXAWDEMLSA-N 0.000 claims description 6
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical group C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 239000011593 sulfur Chemical group 0.000 claims description 6
- VCNBCLDATFDNLA-DOTOQJQBSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(ON=1)=NC=1C1=CC=CS1 VCNBCLDATFDNLA-DOTOQJQBSA-N 0.000 claims description 5
- AICXVAPPRIPRMH-OXJNMPFZSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(N=1)=NOC=1C1=CC=C(C(F)(F)F)C=C1 AICXVAPPRIPRMH-OXJNMPFZSA-N 0.000 claims description 5
- JGSGMZISZMLHJT-RBISFHTESA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(3s)-3-methyl-4-[[5-(4-phenylphenyl)-1,2-oxazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CC(=NO1)C=C1C(C=C1)=CC=C1C1=CC=CC=C1 JGSGMZISZMLHJT-RBISFHTESA-N 0.000 claims description 5
- UYQLICCQQPOQNJ-HTAPYJJXSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(3s)-3-methyl-4-[[5-[4-(trifluoromethyl)phenyl]-1,2-oxazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CC(=NO1)C=C1C1=CC=C(C(F)(F)F)C=C1 UYQLICCQQPOQNJ-HTAPYJJXSA-N 0.000 claims description 5
- WVFQHFYKKPXEJI-OXJNMPFZSA-N (2r)-1-[(2s)-4-[[5-(3,4-dichlorophenyl)-1,2-oxazol-3-yl]methyl]-2-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(=NO1)C=C1C1=CC=C(Cl)C(Cl)=C1 WVFQHFYKKPXEJI-OXJNMPFZSA-N 0.000 claims description 5
- BQWKKBAHGCPBKS-FXAWDEMLSA-N (2r)-1-[(3s)-4-[[5-(2-chlorophenyl)-1,2-oxazol-3-yl]methyl]-3-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CC(=NO1)C=C1C1=CC=CC=C1Cl BQWKKBAHGCPBKS-FXAWDEMLSA-N 0.000 claims description 5
- YVXKOKIBCYGIIP-OXJNMPFZSA-N (2r)-1-[(3s)-4-[[5-(3,4-dichlorophenyl)-1,2-oxazol-3-yl]methyl]-3-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CC(=NO1)C=C1C1=CC=C(Cl)C(Cl)=C1 YVXKOKIBCYGIIP-OXJNMPFZSA-N 0.000 claims description 5
- CUIODTSNCRPHNZ-HTAPYJJXSA-N (2r)-1-[(3s)-4-[[5-(4-chlorophenyl)-1,2-oxazol-3-yl]methyl]-3-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CC(=NO1)C=C1C1=CC=C(Cl)C=C1 CUIODTSNCRPHNZ-HTAPYJJXSA-N 0.000 claims description 5
- WXQZGMFZSUJXEE-JOCHJYFZSA-N (2r)-1-[4-[[3-(4-tert-butylphenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=C(C(C)(C)C)C=C1 WXQZGMFZSUJXEE-JOCHJYFZSA-N 0.000 claims description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 5
- JSNVQPBGRONSNK-LAUBAEHRSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[[2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(O1)=CN=C1C1=CC=C(C(F)(F)F)C=C1 JSNVQPBGRONSNK-LAUBAEHRSA-N 0.000 claims description 4
- KGEGGVBYJAWADY-HTAPYJJXSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(3s)-3-methyl-4-[[2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-4-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CC(N=1)=CSC=1C1=CC=C(C(F)(F)F)C=C1 KGEGGVBYJAWADY-HTAPYJJXSA-N 0.000 claims description 4
- CKMUYZOEMJMTIC-OXJNMPFZSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(3s)-3-methyl-4-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CC(N=1)=NOC=1C1=CC=C(C(F)(F)F)C=C1 CKMUYZOEMJMTIC-OXJNMPFZSA-N 0.000 claims description 4
- VDXGMOFLRLHAQM-OAQYLSRUSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[(2-phenyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(N=1)=CSC=1C1=CC=CC=C1 VDXGMOFLRLHAQM-OAQYLSRUSA-N 0.000 claims description 4
- YMMHPNLFOKKVJQ-LJQANCHMSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[3-(2-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=CC=C1C YMMHPNLFOKKVJQ-LJQANCHMSA-N 0.000 claims description 4
- DHCRXTRJCGTSHC-LJQANCHMSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-(2-methylphenyl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(N=1)=NOC=1C1=CC=CC=C1C DHCRXTRJCGTSHC-LJQANCHMSA-N 0.000 claims description 4
- YRRXMFURJGMFCR-LJQANCHMSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(N=1)=NOC=1C1=CC=CC(C(F)(F)F)=C1 YRRXMFURJGMFCR-LJQANCHMSA-N 0.000 claims description 4
- QQKJIZOFAXRQPI-LJQANCHMSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(N=1)=NOC=1C1=CC=C(C(F)(F)F)C=C1 QQKJIZOFAXRQPI-LJQANCHMSA-N 0.000 claims description 4
- RNZHYYIGCHVHSY-HTAPYJJXSA-N (2r)-1-[(3s)-4-[[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl]-3-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CC(N=1)=CSC=1C1=CC=C(Cl)C=C1 RNZHYYIGCHVHSY-HTAPYJJXSA-N 0.000 claims description 4
- SPNSEIHFSBHQCS-MAUKXSAKSA-N (2r)-1-[(3s)-4-[[5-(2,4-dichlorophenyl)-1,2,4-oxadiazol-3-yl]methyl]-3-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CC(N=1)=NOC=1C1=CC=C(Cl)C=C1Cl SPNSEIHFSBHQCS-MAUKXSAKSA-N 0.000 claims description 4
- OSSJCLRFMVPXOU-QGZVFWFLSA-N (2r)-1-[4-[[3-(2,4-dichlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=C(Cl)C=C1Cl OSSJCLRFMVPXOU-QGZVFWFLSA-N 0.000 claims description 4
- LRCLREIUBOJVPA-QGZVFWFLSA-N (2r)-1-[4-[[3-(2-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=CC=C1F LRCLREIUBOJVPA-QGZVFWFLSA-N 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 238000004132 cross linking Methods 0.000 claims description 4
- 208000014674 injury Diseases 0.000 claims description 4
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 4
- RJKBOQFQCANMGI-YADARESESA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[(5-naphthalen-2-yl-1,3,4-oxadiazol-2-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C1=C2SC(C)=NC2=CC(OC[C@H](O)CN2CCN(CC=3OC(=NN=3)C=3C=C4C=CC=CC4=CC=3)C[C@@H]2C)=C1 RJKBOQFQCANMGI-YADARESESA-N 0.000 claims description 3
- IKEWPSAPIZVTAL-FXAWDEMLSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(O1)=NN=C1C1=CC=CC=C1 IKEWPSAPIZVTAL-FXAWDEMLSA-N 0.000 claims description 3
- NDSHQTCYWXQASZ-GHTZIAJQSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(O1)=NN=C1C1=CC=C(C)C=C1 NDSHQTCYWXQASZ-GHTZIAJQSA-N 0.000 claims description 3
- LNCXVSZKKRYSSX-HFZDXXHNSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[[5-(4-phenylphenyl)-1,3,4-oxadiazol-2-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(O1)=NN=C1C(C=C1)=CC=C1C1=CC=CC=C1 LNCXVSZKKRYSSX-HFZDXXHNSA-N 0.000 claims description 3
- KPVYGVIZUZUPPC-OXJNMPFZSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[[5-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(N=1)=NOC=1C1=CC=CC(C(F)(F)F)=C1 KPVYGVIZUZUPPC-OXJNMPFZSA-N 0.000 claims description 3
- URKMPPOPIUNMJF-OXJNMPFZSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(O1)=NN=C1C1=CC=CC(C(F)(F)F)=C1 URKMPPOPIUNMJF-OXJNMPFZSA-N 0.000 claims description 3
- ZGHVIIJLPOFJJM-HSZRJFAPSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[(5-phenyl-1,3-benzoxazol-2-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(OC1=CC=2)=NC1=CC=2C1=CC=CC=C1 ZGHVIIJLPOFJJM-HSZRJFAPSA-N 0.000 claims description 3
- UXSSVYXASPLXNG-HXUWFJFHSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(O1)=NN=C1C1=CC=C(C)C=C1 UXSSVYXASPLXNG-HXUWFJFHSA-N 0.000 claims description 3
- CEMUEODTOMXPLI-RUZDIDTESA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-(4-phenylphenyl)-1,3,4-oxadiazol-2-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(O1)=NN=C1C(C=C1)=CC=C1C1=CC=CC=C1 CEMUEODTOMXPLI-RUZDIDTESA-N 0.000 claims description 3
- MYZTUCDTQOUYHW-LJQANCHMSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(O1)=NN=C1C1=CC=CC(C(F)(F)F)=C1 MYZTUCDTQOUYHW-LJQANCHMSA-N 0.000 claims description 3
- YVINUCTXLVXVHS-LJQANCHMSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(O1)=NN=C1C1=CC=C(C(F)(F)F)C=C1 YVINUCTXLVXVHS-LJQANCHMSA-N 0.000 claims description 3
- SPJSAUKGKYMVBM-MAUKXSAKSA-N (2r)-1-[(2s)-4-[[3-(2,4-dichlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-2-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(ON=1)=NC=1C1=CC=C(Cl)C=C1Cl SPJSAUKGKYMVBM-MAUKXSAKSA-N 0.000 claims description 3
- MMGFFJCZGMMREQ-FUHWJXTLSA-N (2r)-1-[(2s)-4-[[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-2-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(O1)=NN=C1C1=CC=CC=C1Cl MMGFFJCZGMMREQ-FUHWJXTLSA-N 0.000 claims description 3
- IUQUTXQBQHHBDK-OXJNMPFZSA-N (2r)-1-[(2s)-4-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-2-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(O1)=NN=C1C1=CC=C(Cl)C=C1 IUQUTXQBQHHBDK-OXJNMPFZSA-N 0.000 claims description 3
- CPOHQYINAICFMH-FXAWDEMLSA-N (2r)-1-[(2s)-4-[[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methyl]-2-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C1=CC(OC)=CC=C1C(O1)=NN=C1CN1C[C@H](C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CC1 CPOHQYINAICFMH-FXAWDEMLSA-N 0.000 claims description 3
- IQTJYNABDCLEEH-OAQYLSRUSA-N (2r)-1-[4-[[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(N=1)=CSC=1C1=CC=C(Cl)C=C1 IQTJYNABDCLEEH-OAQYLSRUSA-N 0.000 claims description 3
- PDMBJTHLKZUGND-QGZVFWFLSA-N (2r)-1-[4-[[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(N=1)=NOC=1C1=CC=CC=C1F PDMBJTHLKZUGND-QGZVFWFLSA-N 0.000 claims description 3
- JLICQZZTJAHOOF-LJQANCHMSA-N (2r)-1-[4-[[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C1=CC(OC)=CC=C1C(O1)=NN=C1CN1CCN(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CC1 JLICQZZTJAHOOF-LJQANCHMSA-N 0.000 claims description 3
- PCWGBLKAGJPHPN-JOCHJYFZSA-N (2r)-1-[4-[[5-(4-tert-butylphenyl)-1,3,4-oxadiazol-2-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(O1)=NN=C1C1=CC=C(C(C)(C)C)C=C1 PCWGBLKAGJPHPN-JOCHJYFZSA-N 0.000 claims description 3
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical group C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 3
- 230000035939 shock Effects 0.000 claims description 3
- 238000002054 transplantation Methods 0.000 claims description 3
- 230000008733 trauma Effects 0.000 claims description 3
- BQZWPOOITGBNEH-HSZRJFAPSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[(5-naphthalen-2-yl-1,3,4-oxadiazol-2-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C1=CC=CC2=CC(C3=NN=C(O3)CN3CCN(CC3)C[C@@H](O)COC=3C=C4N=C(SC4=CC=3)C)=CC=C21 BQZWPOOITGBNEH-HSZRJFAPSA-N 0.000 claims description 2
- WYDWTECDFUFLJT-OAQYLSRUSA-N (2r)-1-[4-[[5-(4-chlorophenyl)-1,2-oxazol-3-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(=NO1)C=C1C1=CC=C(Cl)C=C1 WYDWTECDFUFLJT-OAQYLSRUSA-N 0.000 claims description 2
- VFVIRYSVZLPKMG-OAQYLSRUSA-N (2r)-1-[4-[[5-[4-(dimethylamino)phenyl]-1,3,4-oxadiazol-2-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C1=CC(N(C)C)=CC=C1C(O1)=NN=C1CN1CCN(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CC1 VFVIRYSVZLPKMG-OAQYLSRUSA-N 0.000 claims description 2
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical group C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 claims description 2
- QQKJIZOFAXRQPI-UHFFFAOYSA-N 1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C=1C=C2SC(C)=NC2=CC=1OCC(O)CN(CC1)CCN1CC(N=1)=NOC=1C1=CC=C(C(F)(F)F)C=C1 QQKJIZOFAXRQPI-UHFFFAOYSA-N 0.000 claims description 2
- 230000009977 dual effect Effects 0.000 claims description 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 2
- 235000012054 meals Nutrition 0.000 claims description 2
- 210000000056 organ Anatomy 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical group C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 claims 2
- WVFQHFYKKPXEJI-JXFKEZNVSA-N (2s)-1-[(2s)-4-[[5-(3,4-dichlorophenyl)-1,2-oxazol-3-yl]methyl]-2-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(=NO1)C=C1C1=CC=C(Cl)C(Cl)=C1 WVFQHFYKKPXEJI-JXFKEZNVSA-N 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract description 25
- 230000001746 atrial effect Effects 0.000 abstract description 7
- 230000036470 plasma concentration Effects 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 93
- 238000002360 preparation method Methods 0.000 description 81
- 239000000203 mixture Substances 0.000 description 76
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 65
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 64
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- 238000006243 chemical reaction Methods 0.000 description 60
- 239000000243 solution Substances 0.000 description 57
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 51
- 125000001424 substituent group Chemical group 0.000 description 51
- 239000002904 solvent Substances 0.000 description 49
- 230000002829 reductive effect Effects 0.000 description 46
- 239000000047 product Substances 0.000 description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 32
- 230000003647 oxidation Effects 0.000 description 30
- 238000007254 oxidation reaction Methods 0.000 description 30
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 28
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 28
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 27
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 27
- 239000004480 active ingredient Substances 0.000 description 26
- 239000008103 glucose Substances 0.000 description 26
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 26
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 25
- 125000004181 carboxyalkyl group Chemical group 0.000 description 25
- 125000004093 cyano group Chemical group *C#N 0.000 description 24
- 239000012442 inert solvent Substances 0.000 description 24
- 125000003342 alkenyl group Chemical group 0.000 description 22
- 238000007796 conventional method Methods 0.000 description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- 239000004615 ingredient Substances 0.000 description 20
- 125000000304 alkynyl group Chemical group 0.000 description 19
- 239000003826 tablet Substances 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 125000000392 cycloalkenyl group Chemical group 0.000 description 18
- 230000010412 perfusion Effects 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 17
- 150000001412 amines Chemical class 0.000 description 17
- 229940086542 triethylamine Drugs 0.000 description 17
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 15
- 235000014113 dietary fatty acids Nutrition 0.000 description 15
- 239000000194 fatty acid Substances 0.000 description 15
- 229930195729 fatty acid Natural products 0.000 description 15
- 150000004665 fatty acids Chemical class 0.000 description 15
- DXYYSGDWQCSKKO-UHFFFAOYSA-N 2-methylbenzothiazole Chemical compound C1=CC=C2SC(C)=NC2=C1 DXYYSGDWQCSKKO-UHFFFAOYSA-N 0.000 description 14
- 238000004587 chromatography analysis Methods 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 14
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 14
- 239000003921 oil Substances 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- 150000003839 salts Chemical class 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 12
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 125000004414 alkyl thio group Chemical group 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- YBJJKPOQWUEERM-GFCCVEGCSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-piperazin-1-ylpropan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N1CCNCC1 YBJJKPOQWUEERM-GFCCVEGCSA-N 0.000 description 10
- 229930194542 Keto Natural products 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 125000002252 acyl group Chemical group 0.000 description 10
- 125000004442 acylamino group Chemical group 0.000 description 10
- 125000004423 acyloxy group Chemical group 0.000 description 10
- 125000005110 aryl thio group Chemical group 0.000 description 10
- 125000004104 aryloxy group Chemical group 0.000 description 10
- 239000002585 base Substances 0.000 description 10
- 230000000747 cardiac effect Effects 0.000 description 10
- 125000005553 heteroaryloxy group Chemical group 0.000 description 10
- 125000000468 ketone group Chemical group 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 150000007530 organic bases Chemical class 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 10
- 150000003573 thiols Chemical class 0.000 description 10
- 125000000033 alkoxyamino group Chemical group 0.000 description 9
- 125000006598 aminocarbonylamino group Chemical group 0.000 description 9
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 9
- 230000034659 glycolysis Effects 0.000 description 9
- 125000005368 heteroarylthio group Chemical group 0.000 description 9
- 125000004470 heterocyclooxy group Chemical group 0.000 description 9
- 125000004468 heterocyclylthio group Chemical group 0.000 description 9
- 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 description 9
- 239000003112 inhibitor Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- 125000000547 substituted alkyl group Chemical group 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 8
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 8
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 8
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 150000002430 hydrocarbons Chemical group 0.000 description 7
- 238000012746 preparative thin layer chromatography Methods 0.000 description 7
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 7
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 7
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 6
- LAKVUPMDDFICNR-UHFFFAOYSA-N 2-methyl-1,3-benzothiazol-5-ol Chemical compound OC1=CC=C2SC(C)=NC2=C1 LAKVUPMDDFICNR-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 235000019359 magnesium stearate Nutrition 0.000 description 6
- 238000004237 preparative chromatography Methods 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 6
- IPCSVZSSVZVIGE-BFDQMJDGSA-N 5-tritiohexadecanoic acid Chemical compound C(CCCC(CCCCCCCCCCC)[3H])(=O)O IPCSVZSSVZVIGE-BFDQMJDGSA-N 0.000 description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000003818 flash chromatography Methods 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 5
- 239000008108 microcrystalline cellulose Substances 0.000 description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 5
- 150000004885 piperazines Chemical class 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000003586 protic polar solvent Substances 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 5
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 4
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 230000002107 myocardial effect Effects 0.000 description 4
- 150000002825 nitriles Chemical class 0.000 description 4
- 150000002923 oximes Chemical class 0.000 description 4
- 230000036284 oxygen consumption Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 230000036316 preload Effects 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 229930195734 saturated hydrocarbon Natural products 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- 125000005017 substituted alkenyl group Chemical group 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- 235000012222 talc Nutrition 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- HOUIDRMAUWOPLD-SECBINFHSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]butan-2-ol Chemical compound CC[C@@H](O)COC1=CC=C2SC(C)=NC2=C1 HOUIDRMAUWOPLD-SECBINFHSA-N 0.000 description 3
- FDBNPKUPOWQFSS-KRWDZBQOSA-N (2s)-1-[4-[[3-(2,3-dichlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C1=CC=CC(Cl)=C1Cl FDBNPKUPOWQFSS-KRWDZBQOSA-N 0.000 description 3
- 125000001766 1,2,4-oxadiazol-3-yl group Chemical group [H]C1=NC(*)=NO1 0.000 description 3
- 125000004505 1,2,4-oxadiazol-5-yl group Chemical group O1N=CN=C1* 0.000 description 3
- BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 3
- XCARGDPHZYJCMU-UHFFFAOYSA-N 2-chloro-n'-hydroxyethanimidamide Chemical compound ClCC(N)=NO XCARGDPHZYJCMU-UHFFFAOYSA-N 0.000 description 3
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 3
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 3
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 3
- ZLQQUIHBQATFOP-UHFFFAOYSA-N 3-(4-tert-butylphenyl)-5-(chloromethyl)-1,2,4-oxadiazole Chemical compound C1=CC(C(C)(C)C)=CC=C1C1=NOC(CCl)=N1 ZLQQUIHBQATFOP-UHFFFAOYSA-N 0.000 description 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 3
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- 230000002407 ATP formation Effects 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 3
- XKLMZUWKNUAPSZ-UHFFFAOYSA-N N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide Chemical compound COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC=2C(=CC=CC=2C)C)CC1 XKLMZUWKNUAPSZ-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 150000002118 epoxides Chemical class 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 150000007529 inorganic bases Chemical class 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 125000004499 isoxazol-5-yl group Chemical group O1N=CC=C1* 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical group COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 3
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 238000006213 oxygenation reaction Methods 0.000 description 3
- 229940124531 pharmaceutical excipient Drugs 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 229960000213 ranolazine Drugs 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- BRLQWZUYTZBJKN-GSVOUGTGSA-N (+)-Epichlorohydrin Chemical compound ClC[C@@H]1CO1 BRLQWZUYTZBJKN-GSVOUGTGSA-N 0.000 description 2
- GALUJFBBHASRQV-RUZDIDTESA-N (2r)-1-[(2-cyclohexyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[2-[4-(4-fluorophenyl)-1h-pyrazol-5-yl]ethyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CCC=2C(=CNN=2)C=2C=CC(F)=CC=2)CC1)OC(C=C1N=2)=CC=C1SC=2C1CCCCC1 GALUJFBBHASRQV-RUZDIDTESA-N 0.000 description 2
- XDFFMCMLTUBMSI-OXJNMPFZSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[[5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(O1)=NN=C1C1=CC=C(C(F)(F)F)C=C1 XDFFMCMLTUBMSI-OXJNMPFZSA-N 0.000 description 2
- OZSCWIMSAIWZJM-LJQANCHMSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=C(C(F)(F)F)C=C1 OZSCWIMSAIWZJM-LJQANCHMSA-N 0.000 description 2
- RUNBOJDMFNPVOB-GOSISDBHSA-N (2r)-1-[4-[[3-(2-fluorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C1=CC=CC=C1F RUNBOJDMFNPVOB-GOSISDBHSA-N 0.000 description 2
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- UDEADLUKAYYZNF-ONNFQVAWSA-N (ne)-n-[(2,3-dichlorophenyl)methylidene]hydroxylamine Chemical compound O\N=C\C1=CC=CC(Cl)=C1Cl UDEADLUKAYYZNF-ONNFQVAWSA-N 0.000 description 2
- HDPNBNXLBDFELL-UHFFFAOYSA-N 1,1,1-trimethoxyethane Chemical class COC(C)(OC)OC HDPNBNXLBDFELL-UHFFFAOYSA-N 0.000 description 2
- 125000004509 1,3,4-oxadiazol-2-yl group Chemical group O1C(=NN=C1)* 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- OHIMGDQOEPFSSL-UHFFFAOYSA-N 1-(2-chloroethyl)-4-(4-fluorophenyl)pyrazole Chemical compound C1=CC(F)=CC=C1C1=CN(CCCl)N=C1 OHIMGDQOEPFSSL-UHFFFAOYSA-N 0.000 description 2
- AWACTBIAMFXSIT-UHFFFAOYSA-N 1-(2-chloroethyl)-4-iodopyrazole Chemical compound ClCCN1C=C(I)C=N1 AWACTBIAMFXSIT-UHFFFAOYSA-N 0.000 description 2
- SGPXVDUKDPINQL-UHFFFAOYSA-N 1-(2-fluorophenoxy)-3-piperazin-1-ylpropan-2-ol Chemical compound C1CNCCN1CC(O)COC1=CC=CC=C1F SGPXVDUKDPINQL-UHFFFAOYSA-N 0.000 description 2
- CEWDRCQPGANDRS-UHFFFAOYSA-N 1-ethenyl-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(C=C)C=C1 CEWDRCQPGANDRS-UHFFFAOYSA-N 0.000 description 2
- KGNQDBQYEBMPFZ-UHFFFAOYSA-N 1-fluoro-4-iodobenzene Chemical compound FC1=CC=C(I)C=C1 KGNQDBQYEBMPFZ-UHFFFAOYSA-N 0.000 description 2
- DEHVYJWJAALCII-UHFFFAOYSA-N 2-(chloromethyl)-5-phenyl-1,3-benzoxazole Chemical compound C=1C=C2OC(CCl)=NC2=CC=1C1=CC=CC=C1 DEHVYJWJAALCII-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- ZGBJAUZQXAADQJ-UHFFFAOYSA-N 2-[(2-fluorophenoxy)methyl]oxirane Chemical compound FC1=CC=CC=C1OCC1OC1 ZGBJAUZQXAADQJ-UHFFFAOYSA-N 0.000 description 2
- NPEIUNVTLXEOLT-UHFFFAOYSA-N 2-chloro-1,1,1-trimethoxyethane Chemical compound COC(CCl)(OC)OC NPEIUNVTLXEOLT-UHFFFAOYSA-N 0.000 description 2
- YSPRCDGVFRVBED-UHFFFAOYSA-N 2-methyl-5-(oxiran-2-ylmethoxy)-1,3-benzothiazole Chemical compound C=1C=C2SC(C)=NC2=CC=1OCC1CO1 YSPRCDGVFRVBED-UHFFFAOYSA-N 0.000 description 2
- YSPRCDGVFRVBED-SECBINFHSA-N 2-methyl-5-[[(2s)-oxiran-2-yl]methoxy]-1,3-benzothiazole Chemical compound C=1C=C2SC(C)=NC2=CC=1OC[C@@H]1CO1 YSPRCDGVFRVBED-SECBINFHSA-N 0.000 description 2
- JOMNTHCQHJPVAZ-UHFFFAOYSA-N 2-methylpiperazine Chemical compound CC1CNCCN1 JOMNTHCQHJPVAZ-UHFFFAOYSA-N 0.000 description 2
- WPSCQFMIKNCXTH-UHFFFAOYSA-N 2-phenyl-1,3-benzoxazol-5-ol Chemical group N=1C2=CC(O)=CC=C2OC=1C1=CC=CC=C1 WPSCQFMIKNCXTH-UHFFFAOYSA-N 0.000 description 2
- YCOKTYBAJSXBTK-UHFFFAOYSA-N 3-(chloromethyl)-5-(3-fluorophenyl)-1,2,4-oxadiazole Chemical compound FC1=CC=CC(C=2ON=C(CCl)N=2)=C1 YCOKTYBAJSXBTK-UHFFFAOYSA-N 0.000 description 2
- JZTPKAROPNTQQV-UHFFFAOYSA-N 3-fluorobenzonitrile Chemical compound FC1=CC=CC(C#N)=C1 JZTPKAROPNTQQV-UHFFFAOYSA-N 0.000 description 2
- SYVNVEGIRVXRQH-UHFFFAOYSA-N 3-fluorobenzoyl chloride Chemical compound FC1=CC=CC(C(Cl)=O)=C1 SYVNVEGIRVXRQH-UHFFFAOYSA-N 0.000 description 2
- RHCRSAQGFBTQGE-NSHDSACASA-N 5-(2-fluorophenyl)-3-[[(3s)-3-methylpiperazin-1-yl]methyl]-1,2-oxazole Chemical compound C1CN[C@@H](C)CN1CC1=NOC(C=2C(=CC=CC=2)F)=C1 RHCRSAQGFBTQGE-NSHDSACASA-N 0.000 description 2
- OFVIHHHWOQCWEK-UHFFFAOYSA-N 5-(chloromethyl)-3-(3-fluorophenyl)-1,2,4-oxadiazole Chemical compound FC1=CC=CC(C=2N=C(CCl)ON=2)=C1 OFVIHHHWOQCWEK-UHFFFAOYSA-N 0.000 description 2
- NIFNXGHHDAXUGO-UHFFFAOYSA-N 5-phenyl-1,3-benzoxazole Chemical group C=1C=C2OC=NC2=CC=1C1=CC=CC=C1 NIFNXGHHDAXUGO-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 description 2
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- FCVSGLPWXVBEHT-UHFFFAOYSA-N [2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-4-yl]methanol Chemical compound OCC1=COC(C=2C=CC(=CC=2)C(F)(F)F)=N1 FCVSGLPWXVBEHT-UHFFFAOYSA-N 0.000 description 2
- AXHZYGAOISWOLE-UHFFFAOYSA-N [3-(4-fluorophenyl)-1,2-oxazol-5-yl]methanol Chemical compound O1C(CO)=CC(C=2C=CC(F)=CC=2)=N1 AXHZYGAOISWOLE-UHFFFAOYSA-N 0.000 description 2
- OKHIABXUENOKGP-UHFFFAOYSA-N [3-(4-fluorophenyl)-1,2-oxazol-5-yl]methyl acetate Chemical compound O1C(COC(=O)C)=CC(C=2C=CC(F)=CC=2)=N1 OKHIABXUENOKGP-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- MJAMCTLGWXIKOT-UHFFFAOYSA-M benzyl-dimethyl-[2-[2-[2-methyl-4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium;hydroxide Chemical compound [OH-].CC1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 MJAMCTLGWXIKOT-UHFFFAOYSA-M 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 2
- 125000006165 cyclic alkyl group Chemical group 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 125000005265 dialkylamine group Chemical group 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000012055 enteric layer Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- MKMLEMDGZCVWJB-UHFFFAOYSA-N ethyl 5-[4-(trifluoromethyl)phenyl]-1,2-oxazole-3-carboxylate Chemical compound O1N=C(C(=O)OCC)C=C1C1=CC=C(C(F)(F)F)C=C1 MKMLEMDGZCVWJB-UHFFFAOYSA-N 0.000 description 2
- WWWSJJPBJGEKKY-UHFFFAOYSA-N ethyl 5-[4-(trifluoromethyl)phenyl]-4,5-dihydro-1,2-oxazole-3-carboxylate Chemical compound C1C(C(=O)OCC)=NOC1C1=CC=C(C(F)(F)F)C=C1 WWWSJJPBJGEKKY-UHFFFAOYSA-N 0.000 description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 125000005549 heteroarylene group Chemical group 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- BHIWKHZACMWKOJ-UHFFFAOYSA-N isobutyric acid methyl ester Natural products COC(=O)C(C)C BHIWKHZACMWKOJ-UHFFFAOYSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 210000005246 left atrium Anatomy 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- NXPSDGKZHWRAII-UHFFFAOYSA-N n'-(3-fluorophenyl)-n-hydroxymethanimidamide Chemical compound ONC=NC1=CC=CC(F)=C1 NXPSDGKZHWRAII-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 239000006199 nebulizer Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- MNBKLUUYKPBKDU-BBECNAHFSA-N palmitoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCCCCCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MNBKLUUYKPBKDU-BBECNAHFSA-N 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 239000008177 pharmaceutical agent Substances 0.000 description 2
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- BRYCUMKDWMEGMK-UHFFFAOYSA-N piperazine-2-carboxamide Chemical compound NC(=O)C1CNCCN1 BRYCUMKDWMEGMK-UHFFFAOYSA-N 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- RIZZXCJMFIGMON-UHFFFAOYSA-N prop-2-ynyl acetate Chemical compound CC(=O)OCC#C RIZZXCJMFIGMON-UHFFFAOYSA-N 0.000 description 2
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 210000001147 pulmonary artery Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000010410 reperfusion Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 239000008247 solid mixture Substances 0.000 description 2
- 238000000935 solvent evaporation Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 125000005156 substituted alkylene group Chemical group 0.000 description 2
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 2
- 150000003457 sulfones Chemical class 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- RWTHEIZJLZKKAQ-UHFFFAOYSA-N tert-butyl 4-[3-(2-fluorophenoxy)-2-hydroxypropyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1CC(O)COC1=CC=CC=C1F RWTHEIZJLZKKAQ-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 description 2
- BRLQWZUYTZBJKN-VKHMYHEASA-N (-)-Epichlorohydrin Chemical group ClC[C@H]1CO1 BRLQWZUYTZBJKN-VKHMYHEASA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- KPZNQGNTUCOOIM-MRXNPFEDSA-N (2r)-1-(2-fluorophenoxy)-3-[4-[[5-[2-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2N=C(ON=2)C=2C(=CC=CC=2)C(F)(F)F)CC1)OC1=CC=CC=C1F KPZNQGNTUCOOIM-MRXNPFEDSA-N 0.000 description 1
- WCOLSIJDDJJYQC-GOSISDBHSA-N (2r)-1-(2-fluorophenoxy)-3-[4-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2N=C(ON=2)C=2C=CC(=CC=2)C(F)(F)F)CC1)OC1=CC=CC=C1F WCOLSIJDDJJYQC-GOSISDBHSA-N 0.000 description 1
- RWSGMHHCXDIKKP-LJQANCHMSA-N (2r)-1-(4-methoxyphenoxy)-3-[4-[[5-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C1=CC(OC)=CC=C1OC[C@H](O)CN1CCN(CC=2N=C(ON=2)C=2C=C(C=CC=2)C(F)(F)F)CC1 RWSGMHHCXDIKKP-LJQANCHMSA-N 0.000 description 1
- QINNCTHSDHEAIZ-RUZDIDTESA-N (2r)-1-[(2-cyclohexyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[2-(4-phenyl-1h-pyrazol-5-yl)ethyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CCC=2C(=CNN=2)C=2C=CC=CC=2)CC1)OC(C=C1N=2)=CC=C1SC=2C1CCCCC1 QINNCTHSDHEAIZ-RUZDIDTESA-N 0.000 description 1
- XZPFPCVUBDHVAD-OAQYLSRUSA-N (2r)-1-[(2-ethyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[2-(4-phenyl-1h-pyrazol-5-yl)ethyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)CC)N(CC1)CCN1CCC1=NNC=C1C1=CC=CC=C1 XZPFPCVUBDHVAD-OAQYLSRUSA-N 0.000 description 1
- AALJUQFNLSCJGL-OAQYLSRUSA-N (2r)-1-[(2-ethyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[2-[4-(4-fluorophenyl)-1h-pyrazol-5-yl]ethyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)CC)N(CC1)CCN1CCC1=NNC=C1C1=CC=C(F)C=C1 AALJUQFNLSCJGL-OAQYLSRUSA-N 0.000 description 1
- AQJQYFRRJPZLNI-OAQYLSRUSA-N (2r)-1-[(2-ethyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[2-[4-[4-(trifluoromethyl)phenyl]-1h-pyrazol-5-yl]ethyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)CC)N(CC1)CCN1CCC1=NNC=C1C1=CC=C(C(F)(F)F)C=C1 AQJQYFRRJPZLNI-OAQYLSRUSA-N 0.000 description 1
- DJYUXCWVXVHQAO-LJQANCHMSA-N (2r)-1-[(2-ethyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)CC)N(CC1)CCN1CC(N=1)=NOC=1C1=CC=C(C(F)(F)F)C=C1 DJYUXCWVXVHQAO-LJQANCHMSA-N 0.000 description 1
- WYNLFVODYBXRBZ-MRXNPFEDSA-N (2r)-1-[(2-ethyl-1,3-thiazol-4-yl)oxy]-3-[4-[[5-(2-methoxyphenyl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound S1C(CC)=NC(OC[C@H](O)CN2CCN(CC=3N=C(ON=3)C=3C(=CC=CC=3)OC)CC2)=C1 WYNLFVODYBXRBZ-MRXNPFEDSA-N 0.000 description 1
- UYTRKETUCOUOOV-OAHLLOKOSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-(4-propan-2-ylpiperazin-1-yl)propan-2-ol Chemical compound C1CN(C(C)C)CCN1C[C@@H](O)COC1=CC=C(SC(C)=N2)C2=C1 UYTRKETUCOUOOV-OAHLLOKOSA-N 0.000 description 1
- PXLLHUDTQATLGP-PGRDOPGGSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[(3-methyl-5-phenyl-1,2-oxazol-4-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC=1C(C)=NOC=1C1=CC=CC=C1 PXLLHUDTQATLGP-PGRDOPGGSA-N 0.000 description 1
- RNZUHFVMUYJGRY-WMZHIEFXSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[[5-(4-methylphenyl)-1,2-oxazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(=NO1)C=C1C1=CC=C(C)C=C1 RNZUHFVMUYJGRY-WMZHIEFXSA-N 0.000 description 1
- JYXPFHSLLFKCJI-HFZDXXHNSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[[5-(4-phenylphenyl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(N=1)=NOC=1C(C=C1)=CC=C1C1=CC=CC=C1 JYXPFHSLLFKCJI-HFZDXXHNSA-N 0.000 description 1
- HNPIIQVQHDQQLJ-RBISFHTESA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[[5-(4-phenylphenyl)-1,2-oxazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(=NO1)C=C1C(C=C1)=CC=C1C1=CC=CC=C1 HNPIIQVQHDQQLJ-RBISFHTESA-N 0.000 description 1
- QFGPQPICXIIPAD-HTAPYJJXSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[[5-[4-(trifluoromethyl)phenyl]-1,2-oxazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(=NO1)C=C1C1=CC=C(C(F)(F)F)C=C1 QFGPQPICXIIPAD-HTAPYJJXSA-N 0.000 description 1
- RSPAFIOSUPAVIP-WCQYABFASA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methylpiperazin-1-yl]propan-2-ol Chemical compound C[C@H]1CNCCN1C[C@@H](O)COC1=CC=C(SC(C)=N2)C2=C1 RSPAFIOSUPAVIP-WCQYABFASA-N 0.000 description 1
- FILDHIKWXJIORG-PGRDOPGGSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(3s)-3-methyl-4-[(3-methyl-5-phenyl-1,2-oxazol-4-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CC=1C(C)=NOC=1C1=CC=CC=C1 FILDHIKWXJIORG-PGRDOPGGSA-N 0.000 description 1
- WADPVJYOGQQTNE-GBXCKJPGSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(3s)-3-methyl-4-[(5-naphthalen-1-yl-1,2-oxazol-3-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C1=CC=C2C(C3=CC(=NO3)CN3CCN(C[C@@H](O)COC=4C=C5N=C(C)SC5=CC=4)C[C@@H]3C)=CC=CC2=C1 WADPVJYOGQQTNE-GBXCKJPGSA-N 0.000 description 1
- QMURRWIIKYYTTD-WMZHIEFXSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(3s)-3-methyl-4-[[5-(4-methylphenyl)-1,2-oxazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CC(=NO1)C=C1C1=CC=C(C)C=C1 QMURRWIIKYYTTD-WMZHIEFXSA-N 0.000 description 1
- OIEXCIOOXLDXDK-WCQYABFASA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(3s)-3-methylpiperazin-1-yl]propan-2-ol Chemical compound C1CN[C@@H](C)CN1C[C@@H](O)COC1=CC=C(SC(C)=N2)C2=C1 OIEXCIOOXLDXDK-WCQYABFASA-N 0.000 description 1
- DYFCVQIAKHSRPP-QGZVFWFLSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound S1C(C)=NC(CN2CCN(C[C@@H](O)COC=3C=C4N=C(C)SC4=CC=3)CC2)=C1 DYFCVQIAKHSRPP-QGZVFWFLSA-N 0.000 description 1
- OVCARYYVNJTQBF-OAQYLSRUSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[(2-phenyltriazol-4-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(=N1)C=NN1C1=CC=CC=C1 OVCARYYVNJTQBF-OAQYLSRUSA-N 0.000 description 1
- UGSCWZPSXBJBHM-OAQYLSRUSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[(3-methyl-5-phenyl-1,2-oxazol-4-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC=1C(C)=NOC=1C1=CC=CC=C1 UGSCWZPSXBJBHM-OAQYLSRUSA-N 0.000 description 1
- CXVSDWZEYGWUCH-HXUWFJFHSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[(3-phenyl-1,2-oxazol-5-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C1=CC=CC=C1 CXVSDWZEYGWUCH-HXUWFJFHSA-N 0.000 description 1
- QTAYYFJMVXNUMZ-QGZVFWFLSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound O1C(C)=CC(CN2CCN(C[C@@H](O)COC=3C=C4N=C(C)SC4=CC=3)CC2)=N1 QTAYYFJMVXNUMZ-QGZVFWFLSA-N 0.000 description 1
- BGNCVTZUKHNXSQ-HSZRJFAPSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[(5-naphthalen-1-yl-1,2-oxazol-3-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C1=CC=C2C(C3=CC(=NO3)CN3CCN(CC3)C[C@@H](O)COC=3C=C4N=C(SC4=CC=3)C)=CC=CC2=C1 BGNCVTZUKHNXSQ-HSZRJFAPSA-N 0.000 description 1
- OGUBTIWVCCSPPU-OAQYLSRUSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[2-(4-phenyl-1h-pyrazol-5-yl)ethyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CCC1=NNC=C1C1=CC=CC=C1 OGUBTIWVCCSPPU-OAQYLSRUSA-N 0.000 description 1
- QAQAOKJHFKEVKU-OAQYLSRUSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[2-[4-[4-(trifluoromethyl)phenyl]-1h-pyrazol-5-yl]ethyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CCC1=NNC=C1C1=CC=C(C(F)(F)F)C=C1 QAQAOKJHFKEVKU-OAQYLSRUSA-N 0.000 description 1
- VJDPQUCCYIUMDL-MRXNPFEDSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1C1=CC=C(C(F)(F)F)C=N1 VJDPQUCCYIUMDL-MRXNPFEDSA-N 0.000 description 1
- HOAIYBAZRBKXBF-JOCHJYFZSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[2-(3-methylphenyl)triazol-4-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(=N1)C=NN1C1=CC=CC(C)=C1 HOAIYBAZRBKXBF-JOCHJYFZSA-N 0.000 description 1
- LKWWXRBXCVROKU-OAQYLSRUSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-4-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(N=1)=COC=1C1=CC=C(C(F)(F)F)C=C1 LKWWXRBXCVROKU-OAQYLSRUSA-N 0.000 description 1
- YPCGEXFLCGAAEY-HXUWFJFHSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=CC(C)=C1 YPCGEXFLCGAAEY-HXUWFJFHSA-N 0.000 description 1
- HMDHCPQOGKFFEY-RUZDIDTESA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[3-(3-phenylphenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C(C=1)=CC=CC=1C1=CC=CC=C1 HMDHCPQOGKFFEY-RUZDIDTESA-N 0.000 description 1
- HVPKJZFEPCTJTJ-HXUWFJFHSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=C(C)C=C1 HVPKJZFEPCTJTJ-HXUWFJFHSA-N 0.000 description 1
- SQPWSFCGZDJFIK-AREMUKBSSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[3-(4-phenylphenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C(C=C1)=CC=C1C1=CC=CC=C1 SQPWSFCGZDJFIK-AREMUKBSSA-N 0.000 description 1
- ILNJIQZGGVHSFH-JOCHJYFZSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[3-(4-propan-2-ylphenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C1=CC(C(C)C)=CC=C1C1=NOC(CN2CCN(C[C@@H](O)COC=3C=C4N=C(C)SC4=CC=3)CC2)=N1 ILNJIQZGGVHSFH-JOCHJYFZSA-N 0.000 description 1
- LWGQHWANVWGCKT-QGZVFWFLSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[3-[2-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=CC=C1C(F)(F)F LWGQHWANVWGCKT-QGZVFWFLSA-N 0.000 description 1
- JDBBCLDVBLJTQR-HXUWFJFHSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[3-[3-(trifluoromethyl)phenyl]-1,2-oxazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C1=CC=CC(C(F)(F)F)=C1 JDBBCLDVBLJTQR-HXUWFJFHSA-N 0.000 description 1
- IAALHUOCBHXHOP-MUUNZHRXSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[3-[4-(2-phenylethynyl)phenyl]-1,2-oxazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C(C=C1)=CC=C1C#CC1=CC=CC=C1 IAALHUOCBHXHOP-MUUNZHRXSA-N 0.000 description 1
- PYJWWFQOCUNLTA-GOSISDBHSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=C(OC(F)(F)F)C=C1 PYJWWFQOCUNLTA-GOSISDBHSA-N 0.000 description 1
- AACWQDWRPLXNNU-HXUWFJFHSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-(3-methylphenyl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(N=1)=NOC=1C1=CC=CC(C)=C1 AACWQDWRPLXNNU-HXUWFJFHSA-N 0.000 description 1
- DOLMQNMPFLEQDS-HXUWFJFHSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-(4-methylphenyl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(N=1)=NOC=1C1=CC=C(C)C=C1 DOLMQNMPFLEQDS-HXUWFJFHSA-N 0.000 description 1
- YVSZWUZPGARHDV-JOCHJYFZSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-(4-methylphenyl)-1,2-oxazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(=NO1)C=C1C1=CC=C(C)C=C1 YVSZWUZPGARHDV-JOCHJYFZSA-N 0.000 description 1
- VRIDADUFBARZMM-HHHXNRCGSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-(4-phenylphenyl)-1,2-oxazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(=NO1)C=C1C(C=C1)=CC=C1C1=CC=CC=C1 VRIDADUFBARZMM-HHHXNRCGSA-N 0.000 description 1
- WLEDIZGDERNADK-GOSISDBHSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(N=1)=NOC=1C1=CC=C(OC(F)(F)F)C=C1 WLEDIZGDERNADK-GOSISDBHSA-N 0.000 description 1
- PYUAONCDAVXNNW-OAQYLSRUSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-[4-(trifluoromethyl)phenyl]-1,2-oxazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(=NO1)C=C1C1=CC=C(C(F)(F)F)C=C1 PYUAONCDAVXNNW-OAQYLSRUSA-N 0.000 description 1
- PXLDXCBSIMNXHH-CILPGNKCSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-[4-(trifluoromethyl)phenyl]-4,5-dihydro-1,2-oxazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(C1)=NOC1C1=CC=C(C(F)(F)F)C=C1 PXLDXCBSIMNXHH-CILPGNKCSA-N 0.000 description 1
- RUCLPJMBJRMKKT-RHKGEPBNSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-methyl-2-[4-methyl-2-(trifluoromethyl)phenyl]-2h-1,3-thiazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(C=N1)(C)SC1C1=CC=C(C)C=C1C(F)(F)F RUCLPJMBJRMKKT-RHKGEPBNSA-N 0.000 description 1
- UGLWNPUTMXHTCB-UTONKHPSSA-N (2r)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-piperazin-1-ylpropan-2-ol;hydrochloride Chemical compound Cl.C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N1CCNCC1 UGLWNPUTMXHTCB-UTONKHPSSA-N 0.000 description 1
- ZUWTUTKRMXSHLV-HXUWFJFHSA-N (2r)-1-[(2-phenyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2ON=C(N=2)C=2SC=CC=2)CC1)OC(C=C1N=2)=CC=C1SC=2C1=CC=CC=C1 ZUWTUTKRMXSHLV-HXUWFJFHSA-N 0.000 description 1
- MRRQMHUTEBNSIO-RUZDIDTESA-N (2r)-1-[(2-phenyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[2-(4-phenyl-1h-pyrazol-5-yl)ethyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CCC=2C(=CNN=2)C=2C=CC=CC=2)CC1)OC(C=C1N=2)=CC=C1SC=2C1=CC=CC=C1 MRRQMHUTEBNSIO-RUZDIDTESA-N 0.000 description 1
- NAOHRJRSBJUWFY-RUZDIDTESA-N (2r)-1-[(2-phenyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[2-[4-[4-(trifluoromethyl)phenyl]-1h-pyrazol-5-yl]ethyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CCC=2C(=CNN=2)C=2C=CC(=CC=2)C(F)(F)F)CC1)OC(C=C1N=2)=CC=C1SC=2C1=CC=CC=C1 NAOHRJRSBJUWFY-RUZDIDTESA-N 0.000 description 1
- DWFWKMBNIRQURO-MRXNPFEDSA-N (2r)-1-[(2-phenyl-1,3-benzoxazol-5-yl)oxy]-3-piperazin-1-ylpropan-2-ol Chemical compound C([C@H](O)CN1CCNCC1)OC(C=C1N=2)=CC=C1OC=2C1=CC=CC=C1 DWFWKMBNIRQURO-MRXNPFEDSA-N 0.000 description 1
- MSTDTZGPCLDHNI-JOCHJYFZSA-N (2r)-1-[(2-propyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[2-[4-[4-(trifluoromethyl)phenyl]-1h-pyrazol-5-yl]ethyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)CCC)N(CC1)CCN1CCC1=NNC=C1C1=CC=C(C(F)(F)F)C=C1 MSTDTZGPCLDHNI-JOCHJYFZSA-N 0.000 description 1
- AXHXSNUWYPYWHB-HXUWFJFHSA-N (2r)-1-[(2-propyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)CCC)N(CC1)CCN1CC(N=1)=NOC=1C1=CC=C(C(F)(F)F)C=C1 AXHXSNUWYPYWHB-HXUWFJFHSA-N 0.000 description 1
- VURLHRNGLBYWME-QFBILLFUSA-N (2r)-1-[(2s)-4-[[3-(3,4-dichlorophenyl)-1,2-oxazol-5-yl]methyl]-2-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(ON=1)=CC=1C1=CC=C(Cl)C(Cl)=C1 VURLHRNGLBYWME-QFBILLFUSA-N 0.000 description 1
- WIDDWKQXALDVSG-JENIJYKNSA-N (2r)-1-[(2s,5s)-4-[[3-(2,6-dichlorophenyl)-1,2-oxazol-5-yl]methyl]-2,5-dimethylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](N(C[C@@H]1C)C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(ON=1)=CC=1C1=C(Cl)C=CC=C1Cl WIDDWKQXALDVSG-JENIJYKNSA-N 0.000 description 1
- DFCAKMJFJWJQKP-DOTOQJQBSA-N (2r)-1-[(3s)-4-[(5-tert-butyl-1,2,4-oxadiazol-3-yl)methyl]-3-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CC1=NOC(C(C)(C)C)=N1 DFCAKMJFJWJQKP-DOTOQJQBSA-N 0.000 description 1
- OXLKSUNSFGAZLC-QFBILLFUSA-N (2r)-1-[(3s)-4-[2-[3-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-1,2-oxazol-5-yl]ethyl]-3-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CCC(ON=1)=CC=1C1=NC=C(C(F)(F)F)C=C1Cl OXLKSUNSFGAZLC-QFBILLFUSA-N 0.000 description 1
- IYHSALQEGUISSL-OXJNMPFZSA-N (2r)-1-[(3s)-4-[[5-(2,4-difluorophenyl)-1,2-oxazol-3-yl]methyl]-3-methylpiperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H]1C)N(C[C@@H](O)COC=2C=C3N=C(C)SC3=CC=2)CCN1CC(=NO1)C=C1C1=CC=C(F)C=C1F IYHSALQEGUISSL-OXJNMPFZSA-N 0.000 description 1
- WEWDEIBQIHXTFY-XMMPIXPASA-N (2r)-1-[2-(2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-[4-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2N=C(ON=2)C=2C=CC(=CC=2)C(F)(F)F)CC1)OCCC(N=1)=COC=1C1=CC=CC=C1 WEWDEIBQIHXTFY-XMMPIXPASA-N 0.000 description 1
- CBUVHYQNOMLCQP-LJQANCHMSA-N (2r)-1-[4-[(3-cyclohexyl-1,2,4-oxadiazol-5-yl)methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1CCCCC1 CBUVHYQNOMLCQP-LJQANCHMSA-N 0.000 description 1
- NFOLVJYLAJOWJP-GOSISDBHSA-N (2r)-1-[4-[(3-cyclopentyl-1,2,4-oxadiazol-5-yl)methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1CCCC1 NFOLVJYLAJOWJP-GOSISDBHSA-N 0.000 description 1
- PFKDWHXLWZTMJH-LJQANCHMSA-N (2r)-1-[4-[(5-cyclohexyl-1,2,4-oxadiazol-3-yl)methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(N=1)=NOC=1C1CCCCC1 PFKDWHXLWZTMJH-LJQANCHMSA-N 0.000 description 1
- HSGKPACGBQYIFD-GOSISDBHSA-N (2r)-1-[4-[(5-cyclopentyl-1,2,4-oxadiazol-3-yl)methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-6-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC1=CC=C2N=C(SC2=C1)C)N(CC1)CCN1CC(N=1)=NOC=1C1CCCC1 HSGKPACGBQYIFD-GOSISDBHSA-N 0.000 description 1
- YLEPJJJATTUCBY-MRXNPFEDSA-N (2r)-1-[4-[(5-tert-butyl-1,2,4-oxadiazol-3-yl)methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC1=NOC(C(C)(C)C)=N1 YLEPJJJATTUCBY-MRXNPFEDSA-N 0.000 description 1
- XSRPQYHGCAXRAH-JOCHJYFZSA-N (2r)-1-[4-[2-(4-phenyl-1h-pyrazol-5-yl)ethyl]piperazin-1-yl]-3-[(2-propyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)CCC)N(CC1)CCN1CCC1=NNC=C1C1=CC=CC=C1 XSRPQYHGCAXRAH-JOCHJYFZSA-N 0.000 description 1
- CJRMTTNNCWRAQS-GOSISDBHSA-N (2r)-1-[4-[2-[3-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-1,2-oxazol-5-yl]ethyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CCC(ON=1)=CC=1C1=NC=C(C(F)(F)F)C=C1Cl CJRMTTNNCWRAQS-GOSISDBHSA-N 0.000 description 1
- IRZSBVZTECHBOR-OAQYLSRUSA-N (2r)-1-[4-[2-[4-(4-fluorophenyl)-1h-pyrazol-5-yl]ethyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CCC1=NNC=C1C1=CC=C(F)C=C1 IRZSBVZTECHBOR-OAQYLSRUSA-N 0.000 description 1
- GGWLLAXTPBMMNG-RUZDIDTESA-N (2r)-1-[4-[2-[4-(4-fluorophenyl)-1h-pyrazol-5-yl]ethyl]piperazin-1-yl]-3-[(2-phenyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CCC=2C(=CNN=2)C=2C=CC(F)=CC=2)CC1)OC(C=C1N=2)=CC=C1SC=2C1=CC=CC=C1 GGWLLAXTPBMMNG-RUZDIDTESA-N 0.000 description 1
- BQCKBQRMTLVSHC-JOCHJYFZSA-N (2r)-1-[4-[2-[4-(4-fluorophenyl)-1h-pyrazol-5-yl]ethyl]piperazin-1-yl]-3-[(2-propyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)CCC)N(CC1)CCN1CCC1=NNC=C1C1=CC=C(F)C=C1 BQCKBQRMTLVSHC-JOCHJYFZSA-N 0.000 description 1
- LJTITBVZNCXXPJ-LEWJYISDSA-N (2r)-1-[4-[[(4s)-2-(4-fluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](N=1)CN2CCN(CC2)C[C@@H](O)COC=2C=C3N=C(SC3=CC=2)C)OC=1C1=CC=C(F)C=C1 LJTITBVZNCXXPJ-LEWJYISDSA-N 0.000 description 1
- DZQWJVPRYWXXFT-AREMUKBSSA-N (2r)-1-[4-[[2-(3-methylphenyl)triazol-4-yl]methyl]piperazin-1-yl]-3-[(2-phenyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound CC1=CC=CC(N2N=C(CN3CCN(C[C@@H](O)COC=4C=C5N=C(SC5=CC=4)C=4C=CC=CC=4)CC3)C=N2)=C1 DZQWJVPRYWXXFT-AREMUKBSSA-N 0.000 description 1
- FDBNPKUPOWQFSS-QGZVFWFLSA-N (2r)-1-[4-[[3-(2,3-dichlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C1=CC=CC(Cl)=C1Cl FDBNPKUPOWQFSS-QGZVFWFLSA-N 0.000 description 1
- JYMQMPMAYPILAU-GOSISDBHSA-N (2r)-1-[4-[[3-(2,4-dichlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C1=CC=C(Cl)C=C1Cl JYMQMPMAYPILAU-GOSISDBHSA-N 0.000 description 1
- JEXNLVYFBFGTAY-HSZRJFAPSA-N (2r)-1-[4-[[3-(2,4-dimethoxyphenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[[2-(3-fluorophenyl)-1,3-benzoxazol-5-yl]oxy]propan-2-ol Chemical compound COC1=CC(OC)=CC=C1C1=NOC(CN2CCN(C[C@@H](O)COC=3C=C4N=C(OC4=CC=3)C=3C=C(F)C=CC=3)CC2)=C1 JEXNLVYFBFGTAY-HSZRJFAPSA-N 0.000 description 1
- WXIMPMDQKVHGEI-HSZRJFAPSA-N (2r)-1-[4-[[3-(2,4-dimethoxyphenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]oxy]propan-2-ol Chemical compound COC1=CC(OC)=CC=C1C1=NOC(CN2CCN(C[C@@H](O)COC=3C=C4N=C(OC4=CC=3)C=3C=CC(F)=CC=3)CC2)=C1 WXIMPMDQKVHGEI-HSZRJFAPSA-N 0.000 description 1
- VWEOWDDVEWOBKO-QGZVFWFLSA-N (2r)-1-[4-[[3-(2,6-dichlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C1=C(Cl)C=CC=C1Cl VWEOWDDVEWOBKO-QGZVFWFLSA-N 0.000 description 1
- BOLITIMIDYCWOF-OAQYLSRUSA-N (2r)-1-[4-[[3-(2,6-dichlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-phenyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2ON=C(C=2)C=2C(=CC=CC=2Cl)Cl)CC1)OC(C=C1N=2)=CC=C1SC=2C1=CC=CC=C1 BOLITIMIDYCWOF-OAQYLSRUSA-N 0.000 description 1
- YNDPDTKBVLEWBW-OAQYLSRUSA-N (2r)-1-[4-[[3-(2,6-dichlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[[2-(3-fluorophenyl)-1,3-benzoxazol-5-yl]oxy]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2ON=C(C=2)C=2C(=CC=CC=2Cl)Cl)CC1)OC(C=C1N=2)=CC=C1OC=2C1=CC=CC(F)=C1 YNDPDTKBVLEWBW-OAQYLSRUSA-N 0.000 description 1
- KCRLQNPECVSULP-OAQYLSRUSA-N (2r)-1-[4-[[3-(2,6-dichlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]oxy]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2ON=C(C=2)C=2C(=CC=CC=2Cl)Cl)CC1)OC(C=C1N=2)=CC=C1OC=2C1=CC=C(F)C=C1 KCRLQNPECVSULP-OAQYLSRUSA-N 0.000 description 1
- ULTRPJVPUUMAEA-GOSISDBHSA-N (2r)-1-[4-[[3-(2-chlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C1=CC=CC=C1Cl ULTRPJVPUUMAEA-GOSISDBHSA-N 0.000 description 1
- CQKQFDQAIABUAV-JOCHJYFZSA-N (2r)-1-[4-[[3-(2-chlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-phenyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2ON=C(C=2)C=2C(=CC=CC=2)Cl)CC1)OC(C=C1N=2)=CC=C1SC=2C1=CC=CC=C1 CQKQFDQAIABUAV-JOCHJYFZSA-N 0.000 description 1
- MKSPKENRASAQPE-JOCHJYFZSA-N (2r)-1-[4-[[3-(2-chlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[[2-(3-fluorophenyl)-1,3-benzoxazol-5-yl]oxy]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2ON=C(C=2)C=2C(=CC=CC=2)Cl)CC1)OC(C=C1N=2)=CC=C1OC=2C1=CC=CC(F)=C1 MKSPKENRASAQPE-JOCHJYFZSA-N 0.000 description 1
- DFJJEJKYPPZMKQ-JOCHJYFZSA-N (2r)-1-[4-[[3-(2-chlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]oxy]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2ON=C(C=2)C=2C(=CC=CC=2)Cl)CC1)OC(C=C1N=2)=CC=C1OC=2C1=CC=C(F)C=C1 DFJJEJKYPPZMKQ-JOCHJYFZSA-N 0.000 description 1
- ACFFQKYRJYRWPH-XMMPIXPASA-N (2r)-1-[4-[[3-(2-ethylphenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]-3-[(2-phenyl-1,3-benzoxazol-5-yl)oxy]propan-2-ol Chemical compound CCC1=CC=CC=C1C1=NOC(CN2CCN(C[C@@H](O)COC=3C=C4N=C(OC4=CC=3)C=3C=CC=CC=3)CC2)=N1 ACFFQKYRJYRWPH-XMMPIXPASA-N 0.000 description 1
- MEMSYEPNRNMTOH-LJQANCHMSA-N (2r)-1-[4-[[3-(2-methoxyphenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound COC1=CC=CC=C1C1=NOC(CN2CCN(C[C@@H](O)COC=3C=C4N=C(C)SC4=CC=3)CC2)=C1 MEMSYEPNRNMTOH-LJQANCHMSA-N 0.000 description 1
- XAHSMHJJCLFMAE-HSZRJFAPSA-N (2r)-1-[4-[[3-(2-methoxyphenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-phenyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound COC1=CC=CC=C1C1=NOC(CN2CCN(C[C@@H](O)COC=3C=C4N=C(SC4=CC=3)C=3C=CC=CC=3)CC2)=C1 XAHSMHJJCLFMAE-HSZRJFAPSA-N 0.000 description 1
- JNTMOIJSFYSNBP-QGZVFWFLSA-N (2r)-1-[4-[[3-(3,4-dichlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=C(Cl)C(Cl)=C1 JNTMOIJSFYSNBP-QGZVFWFLSA-N 0.000 description 1
- GBDCOMBDTHQXQJ-GOSISDBHSA-N (2r)-1-[4-[[3-(3,4-dichlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C1=CC=C(Cl)C(Cl)=C1 GBDCOMBDTHQXQJ-GOSISDBHSA-N 0.000 description 1
- SMGHSWQQLDOYPU-LJQANCHMSA-N (2r)-1-[4-[[3-(3-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=CC(F)=C1 SMGHSWQQLDOYPU-LJQANCHMSA-N 0.000 description 1
- ZOVGEEPGMSEZNT-HSZRJFAPSA-N (2r)-1-[4-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]-3-[(2-phenyl-1,3-benzoxazol-5-yl)oxy]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2ON=C(N=2)C=2C=CC(Cl)=CC=2)CC1)OC(C=C1N=2)=CC=C1OC=2C1=CC=CC=C1 ZOVGEEPGMSEZNT-HSZRJFAPSA-N 0.000 description 1
- BZSZLADAEHAZML-HXUWFJFHSA-N (2r)-1-[4-[[3-(4-chlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C1=CC=C(Cl)C=C1 BZSZLADAEHAZML-HXUWFJFHSA-N 0.000 description 1
- NAGNJLKQQKNRFZ-LJQANCHMSA-N (2r)-1-[4-[[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=C(F)C=C1 NAGNJLKQQKNRFZ-LJQANCHMSA-N 0.000 description 1
- UBBJKTLGUFFASR-HXUWFJFHSA-N (2r)-1-[4-[[3-(4-fluorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C1=CC=C(F)C=C1 UBBJKTLGUFFASR-HXUWFJFHSA-N 0.000 description 1
- XXKQGIFKMUCCAZ-HXUWFJFHSA-N (2r)-1-[4-[[3-(4-methoxyphenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C1=CC(OC)=CC=C1C1=NOC(CN2CCN(C[C@@H](O)COC=3C=C4N=C(C)SC4=CC=3)CC2)=C1 XXKQGIFKMUCCAZ-HXUWFJFHSA-N 0.000 description 1
- PNFRGOXHUHDDAJ-QGZVFWFLSA-N (2r)-1-[4-[[3-[3-chloro-4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=C(C(F)(F)F)C(Cl)=C1 PNFRGOXHUHDDAJ-QGZVFWFLSA-N 0.000 description 1
- ILFRWIHKXDUDIK-LJQANCHMSA-N (2r)-1-[4-[[5-(2-chlorophenyl)-1,2-oxazol-3-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(=NO1)C=C1C1=CC=CC=C1Cl ILFRWIHKXDUDIK-LJQANCHMSA-N 0.000 description 1
- QEECVPVHHWBDJF-QGZVFWFLSA-N (2r)-1-[4-[[5-(3,4-dichlorophenyl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-6-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC1=CC=C2N=C(SC2=C1)C)N(CC1)CCN1CC(N=1)=NOC=1C1=CC=C(Cl)C(Cl)=C1 QEECVPVHHWBDJF-QGZVFWFLSA-N 0.000 description 1
- ZJZSEQXEVJJHSP-LJQANCHMSA-N (2r)-1-[4-[[5-(3,4-dichlorophenyl)-1,2-oxazol-3-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(=NO1)C=C1C1=CC=C(Cl)C(Cl)=C1 ZJZSEQXEVJJHSP-LJQANCHMSA-N 0.000 description 1
- LONDUSKAQPWNJE-MRXNPFEDSA-N (2r)-1-[4-[[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]-3-(2-fluorophenoxy)propan-2-ol Chemical compound CC1=NOC(C)=C1C1=NC(CN2CCN(C[C@@H](O)COC=3C(=CC=CC=3)F)CC2)=NO1 LONDUSKAQPWNJE-MRXNPFEDSA-N 0.000 description 1
- YBUCCFOVPGXPRA-OAQYLSRUSA-N (2r)-1-[4-[[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]-3-[(2-phenyl-1,3-benzoxazol-5-yl)oxy]propan-2-ol Chemical compound CC1=NOC(C)=C1C1=NC(CN2CCN(C[C@@H](O)COC=3C=C4N=C(OC4=CC=3)C=3C=CC=CC=3)CC2)=NO1 YBUCCFOVPGXPRA-OAQYLSRUSA-N 0.000 description 1
- IBQLWIYKCYNJCP-LJQANCHMSA-N (2r)-1-[4-[[5-(3-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-6-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC1=CC=C2N=C(SC2=C1)C)N(CC1)CCN1CC(N=1)=NOC=1C1=CC=CC(F)=C1 IBQLWIYKCYNJCP-LJQANCHMSA-N 0.000 description 1
- VGGBOGBXNWLVLV-LJQANCHMSA-N (2r)-1-[4-[[5-(4-fluorophenyl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]-3-[(2-methyl-1,3-benzothiazol-6-yl)oxy]propan-2-ol Chemical compound C([C@@H](O)COC1=CC=C2N=C(SC2=C1)C)N(CC1)CCN1CC(N=1)=NOC=1C1=CC=C(F)C=C1 VGGBOGBXNWLVLV-LJQANCHMSA-N 0.000 description 1
- IRNHWGYHJGFCGD-GMMLNUAGSA-N (2r)-1-[4-[[5-(4-tert-butylphenyl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]-3-(2-fluorophenoxy)-1-piperazin-1-ylpropan-2-ol Chemical compound C1=CC(C(C)(C)C)=CC=C1C1=NC(CN2CCN(CC2)C([C@@H](O)COC=2C(=CC=CC=2)F)N2CCNCC2)=NO1 IRNHWGYHJGFCGD-GMMLNUAGSA-N 0.000 description 1
- IHRSWFQDIGMIOU-OAQYLSRUSA-N (2r)-1-[4-[[5-(4-tert-butylphenyl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]-3-(2-fluorophenoxy)propan-2-ol Chemical compound C1=CC(C(C)(C)C)=CC=C1C1=NC(CN2CCN(C[C@@H](O)COC=3C(=CC=CC=3)F)CC2)=NO1 IHRSWFQDIGMIOU-OAQYLSRUSA-N 0.000 description 1
- QJRMRTJMJZAZPI-XMMPIXPASA-N (2r)-1-[4-[[5-(4-tert-butylphenyl)-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]-3-(8-fluoronaphthalen-1-yl)oxypropan-2-ol Chemical compound C1=CC(C(C)(C)C)=CC=C1C1=NC(CN2CCN(C[C@@H](O)COC=3C4=C(F)C=CC=C4C=CC=3)CC2)=NO1 QJRMRTJMJZAZPI-XMMPIXPASA-N 0.000 description 1
- OJQLBXDMDKJKHD-OAQYLSRUSA-N (2r)-1-[[2-(2-chlorophenyl)-1,3-benzoxazol-5-yl]oxy]-3-[4-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2N=C(ON=2)C=2C=CC(=CC=2)C(F)(F)F)CC1)OC(C=C1N=2)=CC=C1OC=2C1=CC=CC=C1Cl OJQLBXDMDKJKHD-OAQYLSRUSA-N 0.000 description 1
- UBUJSJXVDCGUMU-HSZRJFAPSA-N (2r)-1-[[2-(3-fluorophenyl)-1,3-benzoxazol-5-yl]oxy]-3-[4-[[3-(2-methoxyphenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound COC1=CC=CC=C1C1=NOC(CN2CCN(C[C@@H](O)COC=3C=C4N=C(OC4=CC=3)C=3C=C(F)C=CC=3)CC2)=C1 UBUJSJXVDCGUMU-HSZRJFAPSA-N 0.000 description 1
- IUBYUVRJYKGHJR-XMMPIXPASA-N (2r)-1-[[2-(3-fluorophenyl)-1,3-benzoxazol-5-yl]oxy]-3-[4-[[3-(4-fluorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2ON=C(C=2)C=2C=CC(F)=CC=2)CC1)OC(C=C1N=2)=CC=C1OC=2C1=CC=CC(F)=C1 IUBYUVRJYKGHJR-XMMPIXPASA-N 0.000 description 1
- QJRUTMJNPBEBOV-FTHRPBJHSA-N (2r)-1-[[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]oxy]-1-[4-[[3-(2,4-dimethoxyphenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound COC1=CC(OC)=CC=C1C1=NOC(CN2CCN(CC2)C(OC=2C=C3N=C(OC3=CC=2)C=2C=CC(Cl)=CC=2)[C@@H](C)O)=C1 QJRUTMJNPBEBOV-FTHRPBJHSA-N 0.000 description 1
- POZXJYGYCJHMMW-HXUWFJFHSA-N (2r)-1-[[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]oxy]-3-[4-[(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2ON=C(N=2)C=2SC=CC=2)CC1)OC(C=C1N=2)=CC=C1OC=2C1=CC=C(Cl)C=C1 POZXJYGYCJHMMW-HXUWFJFHSA-N 0.000 description 1
- KZDKASXFIFUMTJ-OAQYLSRUSA-N (2r)-1-[[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]oxy]-3-[4-[[3-(2,6-dichlorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2ON=C(C=2)C=2C(=CC=CC=2Cl)Cl)CC1)OC(C=C1N=2)=CC=C1OC=2C1=CC=C(Cl)C=C1 KZDKASXFIFUMTJ-OAQYLSRUSA-N 0.000 description 1
- JBQYLDVKVZWAQV-HSZRJFAPSA-N (2r)-1-[[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]oxy]-3-[4-[[3-(2-methoxyphenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound COC1=CC=CC=C1C1=NOC(CN2CCN(C[C@@H](O)COC=3C=C4N=C(OC4=CC=3)C=3C=CC(F)=CC=3)CC2)=C1 JBQYLDVKVZWAQV-HSZRJFAPSA-N 0.000 description 1
- APLFNLFAXPGJLR-XMMPIXPASA-N (2r)-1-[[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]oxy]-3-[4-[[3-(4-fluorophenyl)-1,2-oxazol-5-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2ON=C(C=2)C=2C=CC(F)=CC=2)CC1)OC(C=C1N=2)=CC=C1OC=2C1=CC=C(F)C=C1 APLFNLFAXPGJLR-XMMPIXPASA-N 0.000 description 1
- IAHLNHQEGLFVCK-OAQYLSRUSA-N (2r)-1-[[2-[2-(trifluoromethyl)phenyl]-1,3-benzoxazol-5-yl]oxy]-3-[4-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2N=C(ON=2)C=2C=CC(=CC=2)C(F)(F)F)CC1)OC(C=C1N=2)=CC=C1OC=2C1=CC=CC=C1C(F)(F)F IAHLNHQEGLFVCK-OAQYLSRUSA-N 0.000 description 1
- XXZSCWIHGSMJAL-HSZRJFAPSA-N (2r)-1-[[2-[3-(trifluoromethyl)phenyl]-1,3-benzoxazol-5-yl]oxy]-3-[4-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@H](O)CN1CCN(CC=2N=C(ON=2)C=2C=CC(=CC=2)C(F)(F)F)CC1)OC(C=C1N=2)=CC=C1OC=2C1=CC=CC(C(F)(F)F)=C1 XXZSCWIHGSMJAL-HSZRJFAPSA-N 0.000 description 1
- UYTRKETUCOUOOV-HNNXBMFYSA-N (2s)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-(4-propan-2-ylpiperazin-1-yl)propan-2-ol Chemical compound C1CN(C(C)C)CCN1C[C@H](O)COC1=CC=C(SC(C)=N2)C2=C1 UYTRKETUCOUOOV-HNNXBMFYSA-N 0.000 description 1
- AICXVAPPRIPRMH-JXFKEZNVSA-N (2s)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[(2s)-2-methyl-4-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C([C@@H](N(CC1)C[C@H](O)COC=2C=C3N=C(C)SC3=CC=2)C)N1CC(N=1)=NOC=1C1=CC=C(C(F)(F)F)C=C1 AICXVAPPRIPRMH-JXFKEZNVSA-N 0.000 description 1
- YBJJKPOQWUEERM-LBPRGKRZSA-N (2s)-1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-piperazin-1-ylpropan-2-ol Chemical compound C([C@H](O)COC=1C=C2N=C(SC2=CC=1)C)N1CCNCC1 YBJJKPOQWUEERM-LBPRGKRZSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- GAJJUJUISAFQOD-UHFFFAOYSA-N 1-(1-fluoronaphthalen-2-yl)oxy-3-piperazin-1-ylpropan-2-ol Chemical compound C=1C=C2C=CC=CC2=C(F)C=1OCC(O)CN1CCNCC1 GAJJUJUISAFQOD-UHFFFAOYSA-N 0.000 description 1
- HVPPJURUTODQOY-UHFFFAOYSA-N 1-(2-methoxyphenoxy)-3-piperazin-1-ylpropan-2-ol Chemical compound COC1=CC=CC=C1OCC(O)CN1CCNCC1 HVPPJURUTODQOY-UHFFFAOYSA-N 0.000 description 1
- LOHBUGASUBABIT-UHFFFAOYSA-N 1-(4-methoxyphenoxy)-3-piperazin-1-ylpropan-2-ol Chemical compound C1=CC(OC)=CC=C1OCC(O)CN1CCNCC1 LOHBUGASUBABIT-UHFFFAOYSA-N 0.000 description 1
- NWQJDOGMXCKWPP-UHFFFAOYSA-N 1-(4-methylimidazol-4-yl)oxy-3-piperazin-1-ylpropan-2-ol Chemical compound C1CNCCN1CC(O)COC1(C)C=NC=N1 NWQJDOGMXCKWPP-UHFFFAOYSA-N 0.000 description 1
- JHRVDVXWUZYUTD-UHFFFAOYSA-N 1-(8-fluoronaphthalen-1-yl)oxy-3-piperazin-1-ylpropan-2-ol Chemical compound C=1C=CC2=CC=CC(F)=C2C=1OCC(O)CN1CCNCC1 JHRVDVXWUZYUTD-UHFFFAOYSA-N 0.000 description 1
- QBGTXMSLUMBNOV-UHFFFAOYSA-N 1-[(2-cyclohexyl-1,3-benzothiazol-5-yl)oxy]-3-piperazin-1-ylpropan-2-ol Chemical group C1CNCCN1CC(O)COC(C=C1N=2)=CC=C1SC=2C1CCCCC1 QBGTXMSLUMBNOV-UHFFFAOYSA-N 0.000 description 1
- OIIZRNOFPGQLJW-UHFFFAOYSA-N 1-[(2-ethyl-1,3-thiazol-4-yl)oxy]-3-piperazin-1-ylpropan-2-ol Chemical compound S1C(CC)=NC(OCC(O)CN2CCNCC2)=C1 OIIZRNOFPGQLJW-UHFFFAOYSA-N 0.000 description 1
- WYTMVJXDNPBSLB-UHFFFAOYSA-N 1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[(1-phenylpyrrol-3-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound C=1C=C2SC(C)=NC2=CC=1OCC(O)CN(CC1)CCN1CC(=C1)C=CN1C1=CC=CC=C1 WYTMVJXDNPBSLB-UHFFFAOYSA-N 0.000 description 1
- DYFCVQIAKHSRPP-UHFFFAOYSA-N 1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound S1C(C)=NC(CN2CCN(CC(O)COC=3C=C4N=C(C)SC4=CC=3)CC2)=C1 DYFCVQIAKHSRPP-UHFFFAOYSA-N 0.000 description 1
- QTAYYFJMVXNUMZ-UHFFFAOYSA-N 1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazin-1-yl]propan-2-ol Chemical compound O1C(C)=CC(CN2CCN(CC(O)COC=3C=C4N=C(C)SC4=CC=3)CC2)=N1 QTAYYFJMVXNUMZ-UHFFFAOYSA-N 0.000 description 1
- LKWWXRBXCVROKU-UHFFFAOYSA-N 1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-[4-[[2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-4-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C=1C=C2SC(C)=NC2=CC=1OCC(O)CN(CC1)CCN1CC(N=1)=COC=1C1=CC=C(C(F)(F)F)C=C1 LKWWXRBXCVROKU-UHFFFAOYSA-N 0.000 description 1
- UGLWNPUTMXHTCB-UHFFFAOYSA-N 1-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-3-piperazin-1-ylpropan-2-ol;hydrochloride Chemical compound Cl.C=1C=C2SC(C)=NC2=CC=1OCC(O)CN1CCNCC1 UGLWNPUTMXHTCB-UHFFFAOYSA-N 0.000 description 1
- PSOCQVNBSDJELW-UHFFFAOYSA-N 1-[(2-methyl-3h-benzimidazol-5-yl)oxy]-3-piperazin-1-ylpropan-2-ol Chemical compound C1=C2NC(C)=NC2=CC=C1OCC(O)CN1CCNCC1 PSOCQVNBSDJELW-UHFFFAOYSA-N 0.000 description 1
- PVNBZDJDIUJUCQ-UHFFFAOYSA-N 1-[(2-phenyl-1,3-benzothiazol-5-yl)oxy]propan-2-ol Chemical compound C1(=CC=CC=C1)C=1SC2=C(N=1)C=C(C=C2)OCC(C)O PVNBZDJDIUJUCQ-UHFFFAOYSA-N 0.000 description 1
- DOEIINIZIVKBTL-UHFFFAOYSA-N 1-[(2-phenyl-3h-benzimidazol-5-yl)oxy]-3-piperazin-1-ylpropan-2-ol Chemical compound C1CNCCN1CC(O)COC(C=C1N2)=CC=C1N=C2C1=CC=CC=C1 DOEIINIZIVKBTL-UHFFFAOYSA-N 0.000 description 1
- KSHAWAUMLXMJMU-UHFFFAOYSA-N 1-[4-[(5-methyl-1,2-oxazol-3-yl)methyl]piperazin-1-yl]-3-[(2-phenyl-1,3-benzoxazol-5-yl)oxy]propan-2-ol Chemical compound O1C(C)=CC(CN2CCN(CC(O)COC=3C=C4N=C(OC4=CC=3)C=3C=CC=CC=3)CC2)=N1 KSHAWAUMLXMJMU-UHFFFAOYSA-N 0.000 description 1
- SAWRRDZEGOGKOV-UHFFFAOYSA-N 1-[[2-(3-fluorophenyl)-1,3-benzoxazol-5-yl]oxy]-3-[4-[[2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-4-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C1CN(CC=2N=C(OC=2)C=2C=CC(=CC=2)C(F)(F)F)CCN1CC(O)COC(C=C1N=2)=CC=C1OC=2C1=CC=CC(F)=C1 SAWRRDZEGOGKOV-UHFFFAOYSA-N 0.000 description 1
- QSNUGJWYBCEPBQ-UHFFFAOYSA-N 1-[[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]oxy]-3-[4-[[2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-4-yl]methyl]piperazin-1-yl]propan-2-ol Chemical compound C1CN(CC=2N=C(OC=2)C=2C=CC(=CC=2)C(F)(F)F)CCN1CC(O)COC(C=C1N=2)=CC=C1OC=2C1=CC=C(F)C=C1 QSNUGJWYBCEPBQ-UHFFFAOYSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- IYWQCCHIVFXZML-UHFFFAOYSA-N 1-iodopyrazole Chemical compound IN1C=CC=N1 IYWQCCHIVFXZML-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- VEUMBMHMMCOFAG-UHFFFAOYSA-N 2,3-dihydrooxadiazole Chemical compound N1NC=CO1 VEUMBMHMMCOFAG-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
- JTTKIXKOKLCMST-UHFFFAOYSA-N 2-(1,3-oxazol-4-yl)acetic acid Chemical class OC(=O)CC1=COC=N1 JTTKIXKOKLCMST-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- CKLYNKVPJLVQDN-UHFFFAOYSA-N 2-[(1-fluoronaphthalen-2-yl)oxymethyl]oxirane Chemical compound C1=CC2=CC=CC=C2C(F)=C1OCC1CO1 CKLYNKVPJLVQDN-UHFFFAOYSA-N 0.000 description 1
- RJNVSQLNEALZLC-UHFFFAOYSA-N 2-[(2-methoxyphenoxy)methyl]oxirane Chemical compound COC1=CC=CC=C1OCC1OC1 RJNVSQLNEALZLC-UHFFFAOYSA-N 0.000 description 1
- AVWGFHZLPMLKBL-UHFFFAOYSA-N 2-[(4-methoxyphenoxy)methyl]oxirane Chemical compound C1=CC(OC)=CC=C1OCC1OC1 AVWGFHZLPMLKBL-UHFFFAOYSA-N 0.000 description 1
- MTRCETJEPUOHTJ-UHFFFAOYSA-N 2-[(8-fluoronaphthalen-1-yl)oxymethyl]oxirane Chemical compound C=12C(F)=CC=CC2=CC=CC=1OCC1CO1 MTRCETJEPUOHTJ-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical class CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- LUKMAFPGZSTOEK-UHFFFAOYSA-N 2-[2-(2-chlorophenoxy)ethyl]oxirane Chemical compound ClC1=CC=CC=C1OCCC1OC1 LUKMAFPGZSTOEK-UHFFFAOYSA-N 0.000 description 1
- XWHSQDHACDTMLY-UHFFFAOYSA-N 2-[2-(2-methoxyphenoxy)ethyl]oxirane Chemical compound COC1=CC=CC=C1OCCC1OC1 XWHSQDHACDTMLY-UHFFFAOYSA-N 0.000 description 1
- HQEOVXZKJXZZBW-FQEVSTJZSA-N 2-[4-[5-[[4-[(2s)-2-hydroxy-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propyl]piperazin-1-yl]methyl]-1,2,4-oxadiazol-3-yl]phenoxy]-2-methylpropanoic acid Chemical compound C([C@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=NC=1C1=CC=C(OC(C)(C)C(O)=O)C=C1 HQEOVXZKJXZZBW-FQEVSTJZSA-N 0.000 description 1
- NOIXNOMHHWGUTG-UHFFFAOYSA-N 2-[[4-[4-pyridin-4-yl-1-(2,2,2-trifluoroethyl)pyrazol-3-yl]phenoxy]methyl]quinoline Chemical group C=1C=C(OCC=2N=C3C=CC=CC3=CC=2)C=CC=1C1=NN(CC(F)(F)F)C=C1C1=CC=NC=C1 NOIXNOMHHWGUTG-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- IGIDZGNPFWGICD-UHFFFAOYSA-N 2-amino-4-phenylphenol Chemical compound C1=C(O)C(N)=CC(C=2C=CC=CC=2)=C1 IGIDZGNPFWGICD-UHFFFAOYSA-N 0.000 description 1
- CXUXSVRYIFBRSZ-UHFFFAOYSA-N 2-cyclohexyl-1,3-benzothiazole Chemical compound C1CCCCC1C1=NC2=CC=CC=C2S1 CXUXSVRYIFBRSZ-UHFFFAOYSA-N 0.000 description 1
- YCZLJRIAGHPLRO-UHFFFAOYSA-N 2-ethyl-4-(oxiran-2-ylmethoxy)-1,3-thiazole Chemical compound S1C(CC)=NC(OCC2OC2)=C1 YCZLJRIAGHPLRO-UHFFFAOYSA-N 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- DILGZUDEEZNFOL-UHFFFAOYSA-N 2-methyl-5-[2-(oxiran-2-yl)ethoxy]-1,3-benzothiazole Chemical compound C=1C=C2SC(C)=NC2=CC=1OCCC1CO1 DILGZUDEEZNFOL-UHFFFAOYSA-N 0.000 description 1
- YSPRCDGVFRVBED-VIFPVBQESA-N 2-methyl-5-[[(2r)-oxiran-2-yl]methoxy]-1,3-benzothiazole Chemical compound C=1C=C2SC(C)=NC2=CC=1OC[C@H]1CO1 YSPRCDGVFRVBED-VIFPVBQESA-N 0.000 description 1
- YBIGZIJBVCJGIV-UHFFFAOYSA-N 2-methyl-6-(oxiran-2-ylmethoxy)-1h-benzimidazole Chemical compound C1=C2NC(C)=NC2=CC=C1OCC1CO1 YBIGZIJBVCJGIV-UHFFFAOYSA-N 0.000 description 1
- VLRSADZEDXVUPG-UHFFFAOYSA-N 2-naphthalen-1-ylpyridine Chemical compound N1=CC=CC=C1C1=CC=CC2=CC=CC=C12 VLRSADZEDXVUPG-UHFFFAOYSA-N 0.000 description 1
- FIISKTXZUZBTRC-UHFFFAOYSA-N 2-phenyl-1,3-benzoxazole Chemical compound C1=CC=CC=C1C1=NC2=CC=CC=C2O1 FIISKTXZUZBTRC-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 1
- GDTSJMKGXGJFGQ-UHFFFAOYSA-N 3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound O1B([O-])OB2OB([O-])OB1O2 GDTSJMKGXGJFGQ-UHFFFAOYSA-N 0.000 description 1
- YSXIJTDOCXJNHI-UHFFFAOYSA-N 3-(1,2-oxazol-4-yl)propanoic acid Chemical class OC(=O)CCC=1C=NOC=1 YSXIJTDOCXJNHI-UHFFFAOYSA-N 0.000 description 1
- SQHQKHGSNYSZMC-UHFFFAOYSA-N 3-(3-fluorophenyl)-1,2,4-oxadiazole Chemical compound FC1=CC=CC(C2=NOC=N2)=C1 SQHQKHGSNYSZMC-UHFFFAOYSA-N 0.000 description 1
- HMNSMZAKTCXHNT-UHFFFAOYSA-N 3-(chloromethyl)-5-(2-fluorophenyl)-1,2-oxazole Chemical compound FC1=CC=CC=C1C1=CC(CCl)=NO1 HMNSMZAKTCXHNT-UHFFFAOYSA-N 0.000 description 1
- FOPHIEABULMTDJ-UHFFFAOYSA-N 3-(chloromethyl)-5-[4-(trifluoromethyl)phenyl]-1,2-oxazole Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CC(CCl)=NO1 FOPHIEABULMTDJ-UHFFFAOYSA-N 0.000 description 1
- MHCJLGAMVALBOM-UHFFFAOYSA-N 3-[3-[[4-[2-hydroxy-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propyl]piperazin-1-yl]methyl]-1,2,4-oxadiazol-5-yl]benzonitrile Chemical compound C=1C=C2SC(C)=NC2=CC=1OCC(O)CN(CC1)CCN1CC(N=1)=NOC=1C1=CC=CC(C#N)=C1 MHCJLGAMVALBOM-UHFFFAOYSA-N 0.000 description 1
- HFNOTJAWZLAJEJ-UHFFFAOYSA-N 3-[5-[[4-[2-hydroxy-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propyl]piperazin-1-yl]methyl]-1,2,4-oxadiazol-3-yl]benzonitrile Chemical compound C=1C=C2SC(C)=NC2=CC=1OCC(O)CN(CC1)CCN1CC(ON=1)=NC=1C1=CC=CC(C#N)=C1 HFNOTJAWZLAJEJ-UHFFFAOYSA-N 0.000 description 1
- IBVXLMHGMDOOHY-UHFFFAOYSA-N 4-(2-chlorophenoxy)-1-piperazin-1-ylbutan-2-ol Chemical compound C1CNCCN1CC(O)CCOC1=CC=CC=C1Cl IBVXLMHGMDOOHY-UHFFFAOYSA-N 0.000 description 1
- YBKVBBMEUKHNEB-UHFFFAOYSA-N 4-(2-methoxyphenoxy)-1-piperazin-1-ylbutan-2-ol Chemical compound COC1=CC=CC=C1OCCC(O)CN1CCNCC1 YBKVBBMEUKHNEB-UHFFFAOYSA-N 0.000 description 1
- QOWNNZROJKFRSK-UHFFFAOYSA-N 4-(chloromethyl)-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=NC(CCl)=CS1 QOWNNZROJKFRSK-UHFFFAOYSA-N 0.000 description 1
- GKBDXTNCBPZMFX-UHFFFAOYSA-N 4-(trifluoromethyl)benzohydrazide Chemical compound NNC(=O)C1=CC=C(C(F)(F)F)C=C1 GKBDXTNCBPZMFX-UHFFFAOYSA-N 0.000 description 1
- OXZYBOLWRXENKT-UHFFFAOYSA-N 4-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC=C(C(Cl)=O)C=C1 OXZYBOLWRXENKT-UHFFFAOYSA-N 0.000 description 1
- HDDFKLIJENTKQV-UHFFFAOYSA-N 4-[(2-methyl-1,3-benzothiazol-5-yl)oxy]-1-piperazin-1-ylbutan-2-ol Chemical compound C=1C=C2SC(C)=NC2=CC=1OCCC(O)CN1CCNCC1 HDDFKLIJENTKQV-UHFFFAOYSA-N 0.000 description 1
- AWVFXNHALITFRV-UHFFFAOYSA-N 4-[3-[[4-[2-hydroxy-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propyl]piperazin-1-yl]methyl]-1,2,4-oxadiazol-5-yl]benzonitrile Chemical compound C=1C=C2SC(C)=NC2=CC=1OCC(O)CN(CC1)CCN1CC(N=1)=NOC=1C1=CC=C(C#N)C=C1 AWVFXNHALITFRV-UHFFFAOYSA-N 0.000 description 1
- BXJSORQKXHMDDN-HXUWFJFHSA-N 4-[5-[[4-[(2R)-2-hydroxy-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propyl]piperazin-1-yl]methyl]-1,2-oxazol-3-yl]phenol Chemical compound C([C@@H](O)COC=1C=C2N=C(SC2=CC=1)C)N(CC1)CCN1CC(ON=1)=CC=1C1=CC=C(O)C=C1 BXJSORQKXHMDDN-HXUWFJFHSA-N 0.000 description 1
- AOLHGVYOAFKSLH-UHFFFAOYSA-N 4-[5-[[4-[2-hydroxy-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propyl]piperazin-1-yl]methyl]-1,2,4-oxadiazol-3-yl]benzonitrile Chemical compound C=1C=C2SC(C)=NC2=CC=1OCC(O)CN(CC1)CCN1CC(ON=1)=NC=1C1=CC=C(C#N)C=C1 AOLHGVYOAFKSLH-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- CZMWNOPTKAFPDG-UHFFFAOYSA-N 5-(chloromethyl)-3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazole Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=NOC(CCl)=N1 CZMWNOPTKAFPDG-UHFFFAOYSA-N 0.000 description 1
- PBNORXDZGQAVGW-ZDUSSCGKSA-N 5-[[(2r)-oxiran-2-yl]methoxy]-2-phenyl-1,3-benzothiazole Chemical compound C([C@@H]1OC1)OC(C=C1N=2)=CC=C1SC=2C1=CC=CC=C1 PBNORXDZGQAVGW-ZDUSSCGKSA-N 0.000 description 1
- ODVLVIHWERFNKW-UHFFFAOYSA-N 5-methyl-2-(oxiran-2-ylmethoxy)-1h-imidazole Chemical compound CC1=CNC(OCC2OC2)=N1 ODVLVIHWERFNKW-UHFFFAOYSA-N 0.000 description 1
- BXDMUBIFFZQMQC-UHFFFAOYSA-N 6-(oxiran-2-ylmethoxy)-2-phenyl-1h-benzimidazole Chemical compound C1OC1COC(C=C1N2)=CC=C1N=C2C1=CC=CC=C1 BXDMUBIFFZQMQC-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical group C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 125000006847 BOC protecting group Chemical group 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 229920003134 Eudragit® polymer Polymers 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical group CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 102000006404 Mitochondrial Proteins Human genes 0.000 description 1
- 108010058682 Mitochondrial Proteins Proteins 0.000 description 1
- SOWBFZRMHSNYGE-UHFFFAOYSA-N Monoamide-Oxalic acid Natural products NC(=O)C(O)=O SOWBFZRMHSNYGE-UHFFFAOYSA-N 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 201000001068 Prinzmetal angina Diseases 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GCTFWCDSFPMHHS-UHFFFAOYSA-M Tributyltin chloride Chemical compound CCCC[Sn](Cl)(CCCC)CCCC GCTFWCDSFPMHHS-UHFFFAOYSA-M 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 208000009325 Variant Angina Pectoris Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 229910052769 Ytterbium Inorganic materials 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- HTDMXATWYNKLLE-UHFFFAOYSA-N [5-[4-(trifluoromethyl)phenyl]-1,2-oxazol-3-yl]methanol Chemical compound O1N=C(CO)C=C1C1=CC=C(C(F)(F)F)C=C1 HTDMXATWYNKLLE-UHFFFAOYSA-N 0.000 description 1
- FZQSLXQPHPOTHG-UHFFFAOYSA-N [K+].[K+].O1B([O-])OB2OB([O-])OB1O2 Chemical compound [K+].[K+].O1B([O-])OB2OB([O-])OB1O2 FZQSLXQPHPOTHG-UHFFFAOYSA-N 0.000 description 1
- WRWYGOVGIGCDLE-UHFFFAOYSA-N [O]c1ccccc1F Chemical group [O]c1ccccc1F WRWYGOVGIGCDLE-UHFFFAOYSA-N 0.000 description 1
- 239000003070 absorption delaying agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- CREXVNNSNOKDHW-UHFFFAOYSA-N azaniumylideneazanide Chemical group N[N] CREXVNNSNOKDHW-UHFFFAOYSA-N 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WARCRYXKINZHGQ-UHFFFAOYSA-N benzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1 WARCRYXKINZHGQ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 229960001714 calcium phosphate Drugs 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 229960003340 calcium silicate Drugs 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 231100000223 dermal penetration Toxicity 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000005266 diarylamine group Chemical class 0.000 description 1
- PMPYSSMGWFNAAQ-UHFFFAOYSA-N dichloromethane;n,n-diethylethanamine Chemical compound ClCCl.CCN(CC)CC PMPYSSMGWFNAAQ-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- BVKZGUZCCUSVTD-NJFSPNSNSA-N dihydroxy(114C)methanone Chemical compound O[14C](O)=O BVKZGUZCCUSVTD-NJFSPNSNSA-N 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000007580 dry-mixing Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- WQKPUHLYTDLTAH-QHCPKHFHSA-N ethyl 3-[4-[5-[[4-[(2s)-2-hydroxy-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propyl]piperazin-1-yl]methyl]-1,2,4-oxadiazol-3-yl]phenoxy]-3-methylbutanoate Chemical compound C1=CC(OC(C)(C)CC(=O)OCC)=CC=C1C1=NOC(CN2CCN(C[C@H](O)COC=3C=C4N=C(C)SC4=CC=3)CC2)=N1 WQKPUHLYTDLTAH-QHCPKHFHSA-N 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- 229940012017 ethylenediamine Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 125000004970 halomethyl group Chemical group 0.000 description 1
- 210000004536 heart mitochondria Anatomy 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 125000005241 heteroarylamino group Chemical class 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- NDBQJIBNNUJNHA-UHFFFAOYSA-N hydron;methyl 2-amino-3-hydroxypropanoate;chloride Chemical compound [Cl-].COC(=O)C([NH3+])CO NDBQJIBNNUJNHA-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical compound C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 125000004284 isoxazol-3-yl group Chemical group [H]C1=C([H])C(*)=NO1 0.000 description 1
- 150000002545 isoxazoles Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000030175 lameness Diseases 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- NDBQJIBNNUJNHA-DFWYDOINSA-N methyl (2s)-2-amino-3-hydroxypropanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CO NDBQJIBNNUJNHA-DFWYDOINSA-N 0.000 description 1
- RXTILVJDUGFFKT-UHFFFAOYSA-N methyl 2-[4-(trifluoromethyl)phenyl]-1,3-oxazole-4-carboxylate Chemical compound COC(=O)C1=COC(C=2C=CC(=CC=2)C(F)(F)F)=N1 RXTILVJDUGFFKT-UHFFFAOYSA-N 0.000 description 1
- RQDYZAGLOUDTFE-UHFFFAOYSA-N methyl 2-[4-(trifluoromethyl)phenyl]-4,5-dihydro-1,3-oxazole-4-carboxylate Chemical compound COC(=O)C1COC(C=2C=CC(=CC=2)C(F)(F)F)=N1 RQDYZAGLOUDTFE-UHFFFAOYSA-N 0.000 description 1
- ANSUDRATXSJBLY-UHFFFAOYSA-N methyl 2-amino-3-hydroxypropanoate Chemical compound COC(=O)C(N)CO ANSUDRATXSJBLY-UHFFFAOYSA-N 0.000 description 1
- NNAFQSOVRVRNKE-UHFFFAOYSA-N methyl 3-hydroxy-2-[[4-(trifluoromethyl)benzoyl]amino]propanoate Chemical compound COC(=O)C(CO)NC(=O)C1=CC=C(C(F)(F)F)C=C1 NNAFQSOVRVRNKE-UHFFFAOYSA-N 0.000 description 1
- MCCWTHZNQPICAI-UHFFFAOYSA-N methyl 4,5-dihydro-1,3-oxazole-4-carboxylate Chemical compound COC(=O)C1COC=N1 MCCWTHZNQPICAI-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- UMRZSTCPUPJPOJ-KNVOCYPGSA-N norbornane Chemical compound C1C[C@H]2CC[C@@H]1C2 UMRZSTCPUPJPOJ-KNVOCYPGSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000012053 oil suspension Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000082 organ preservation Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 150000004866 oxadiazoles Chemical class 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- QSYOAKOOQMVVTO-UHFFFAOYSA-N pentan-2-yl 2-methylprop-2-enoate Chemical compound CCCC(C)OC(=O)C(C)=C QSYOAKOOQMVVTO-UHFFFAOYSA-N 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- RFIOZSIHFNEKFF-UHFFFAOYSA-M piperazine-1-carboxylate Chemical compound [O-]C(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-M 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- YORCIIVHUBAYBQ-UHFFFAOYSA-N propargyl bromide Chemical compound BrCC#C YORCIIVHUBAYBQ-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000003345 scintillation counting Methods 0.000 description 1
- 238000011894 semi-preparative HPLC Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000012058 sterile packaged powder Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000004426 substituted alkynyl group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229940066769 systemic antihistamines substituted alkylamines Drugs 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- WGJOUDVKRXFGJF-UHFFFAOYSA-N tert-butyl 4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazine-1-carboxylate Chemical compound COC1=CC=CC=C1OCC(O)CN1CCN(C(=O)OC(C)(C)C)CC1 WGJOUDVKRXFGJF-UHFFFAOYSA-N 0.000 description 1
- JNEBBAKHBROKEQ-UHFFFAOYSA-N tert-butyl 4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]piperazine-1-carboxylate Chemical compound C1=CC(OC)=CC=C1OCC(O)CN1CCN(C(=O)OC(C)(C)C)CC1 JNEBBAKHBROKEQ-UHFFFAOYSA-N 0.000 description 1
- YIQJKYXFVQKBGJ-UHFFFAOYSA-N tert-butyl 4-[2-hydroxy-3-(4-methylimidazol-4-yl)oxypropyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1CC(O)COC1(C)N=CN=C1 YIQJKYXFVQKBGJ-UHFFFAOYSA-N 0.000 description 1
- TWENMNQDGGICPL-UHFFFAOYSA-N tert-butyl 4-[2-hydroxy-3-[(2-methyl-1,3-benzothiazol-5-yl)oxy]propyl]piperazine-1-carboxylate Chemical compound C=1C=C2SC(C)=NC2=CC=1OCC(O)CN1CCN(C(=O)OC(C)(C)C)CC1 TWENMNQDGGICPL-UHFFFAOYSA-N 0.000 description 1
- XPCKEVHSXUMXRE-UHFFFAOYSA-N tert-butyl 4-[2-hydroxy-3-[(2-methyl-3H-benzimidazol-5-yl)oxy]propyl]piperazine-1-carboxylate Chemical compound C(C)(C)(C)OC(=O)N1CCN(CC1)CC(COC1=CC2=C(N=C(N2)C)C=C1)O XPCKEVHSXUMXRE-UHFFFAOYSA-N 0.000 description 1
- JRKIQTUHRLQDGZ-UHFFFAOYSA-N tert-butyl 4-[2-hydroxy-3-[(2-phenyl-1,3-benzoxazol-5-yl)oxy]propyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1CC(O)COC1=CC=C(OC(=N2)C=3C=CC=CC=3)C2=C1 JRKIQTUHRLQDGZ-UHFFFAOYSA-N 0.000 description 1
- AUIXBRCHZDSKLC-UHFFFAOYSA-N tert-butyl 4-[2-hydroxy-3-[(2-phenyl-3h-benzimidazol-5-yl)oxy]propyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1CC(O)COC1=CC=C(N=C(N2)C=3C=CC=CC=3)C2=C1 AUIXBRCHZDSKLC-UHFFFAOYSA-N 0.000 description 1
- IENFLFSMBDWJRG-UHFFFAOYSA-N tert-butyl 4-[2-hydroxy-4-(2-methoxyphenoxy)butyl]piperazine-1-carboxylate Chemical compound COC1=CC=CC=C1OCCC(O)CN1CCN(C(=O)OC(C)(C)C)CC1 IENFLFSMBDWJRG-UHFFFAOYSA-N 0.000 description 1
- CMXUXPHYDAUYBY-UHFFFAOYSA-N tert-butyl 4-[2-hydroxy-4-[(2-methyl-1,3-benzothiazol-5-yl)oxy]butyl]piperazine-1-carboxylate Chemical compound C=1C=C2SC(C)=NC2=CC=1OCCC(O)CN1CCN(C(=O)OC(C)(C)C)CC1 CMXUXPHYDAUYBY-UHFFFAOYSA-N 0.000 description 1
- MZYKRTRAZWZLBH-UHFFFAOYSA-N tert-butyl 4-[3-(1-fluoronaphthalen-2-yl)oxy-2-hydroxypropyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1CC(O)COC1=CC=C(C=CC=C2)C2=C1F MZYKRTRAZWZLBH-UHFFFAOYSA-N 0.000 description 1
- KYAKKAMGAAUBFZ-UHFFFAOYSA-N tert-butyl 4-[3-(8-fluoronaphthalen-1-yl)oxy-2-hydroxypropyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1CC(O)COC1=CC=CC2=CC=CC(F)=C12 KYAKKAMGAAUBFZ-UHFFFAOYSA-N 0.000 description 1
- SHNPJRUSVXSHHY-UHFFFAOYSA-N tert-butyl 4-[3-[(2-ethyl-1,3-thiazol-4-yl)oxy]-2-hydroxypropyl]piperazine-1-carboxylate Chemical compound S1C(CC)=NC(OCC(O)CN2CCN(CC2)C(=O)OC(C)(C)C)=C1 SHNPJRUSVXSHHY-UHFFFAOYSA-N 0.000 description 1
- DCZJYNHYQRCTDU-UHFFFAOYSA-N tert-butyl 4-[4-(2-fluorophenoxy)-2-hydroxybutyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1CC(O)CCOC1=CC=CC=C1F DCZJYNHYQRCTDU-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- 125000005259 triarylamine group Chemical class 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- AHZJKOKFZJYCLG-UHFFFAOYSA-K trifluoromethanesulfonate;ytterbium(3+) Chemical compound [Yb+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F AHZJKOKFZJYCLG-UHFFFAOYSA-K 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 208000020854 vein disease Diseases 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/346,684 | 2003-01-17 | ||
| US10/346,684 US7001909B2 (en) | 2001-07-19 | 2003-01-17 | Substituted heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20050092421A true KR20050092421A (ko) | 2005-09-21 |
Family
ID=32823684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020057013173A Ceased KR20050092421A (ko) | 2003-01-17 | 2004-01-16 | 치환된 헤테로시클릭 화합물 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7001909B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1583760A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006516036A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20050092421A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004207764C1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2513641A1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ541307A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004067506A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004069818A1 (en) * | 2003-01-17 | 2004-08-19 | Cv Therapeutics Inc. | Substituted heterocyclic compounds useful in the treatment of cardiovascular diseases |
| CA2550257A1 (en) | 2003-12-18 | 2005-07-07 | Cv Therapeutics, Inc. | 1-akan-2-ol substituted piperazine and piperidine compounds |
| US7271169B2 (en) * | 2004-09-08 | 2007-09-18 | Cv Therapeutics, Inc. | Substituted heterocyclic compounds |
| CN106496212B (zh) * | 2016-10-12 | 2019-11-15 | 贵州大学 | 一种吡唑联噁二唑硫醚类化合物及其制备方法与应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1133989A (en) * | 1964-12-08 | 1968-11-20 | Chugai Pharmaceutical Co Ltd | Theophylline derivatives, their salts and process for preparing the same |
| US4567264A (en) * | 1983-05-18 | 1986-01-28 | Syntex (U.S.A.) Inc. | Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry |
| US4723014A (en) * | 1986-11-19 | 1988-02-02 | Warner-Lambert Company | Process for the preparation of 2-substituted-1,4-dihydropyridines |
| JPH02268162A (ja) * | 1989-04-10 | 1990-11-01 | Fujisawa Pharmaceut Co Ltd | ジフェニルピリジン誘導体 |
| SE9904765D0 (sv) * | 1999-12-23 | 1999-12-23 | Astra Ab | Pharmaceutically-useful compounds |
| NZ520782A (en) | 2000-02-22 | 2004-03-26 | Cv Therapeutics Inc | Substituted piperazine compounds that are partial fatty acid oxidation inhibitors |
| US6552023B2 (en) * | 2000-02-22 | 2003-04-22 | Cv Therapeutics, Inc. | Aralkyl substituted piperazine compounds |
| US6451798B2 (en) * | 2000-02-22 | 2002-09-17 | Cv Therapeutics, Inc. | Substituted alkyl piperazine derivatives |
| AU2001238590A1 (en) * | 2000-02-22 | 2001-09-03 | Cv Therapeutics, Inc. | Substituted piperazine compounds |
| US6573264B1 (en) * | 2000-10-23 | 2003-06-03 | Cv Therapeutics, Inc. | Heteroaryl alkyl piperazine derivatives |
| MXPA04000565A (es) * | 2001-07-19 | 2005-06-17 | Cv Therapeutics Inc | Compuestos de piperazina sustituidos y su uso como inhibidores de oxidacion de acidos grasos. |
-
2003
- 2003-01-17 US US10/346,684 patent/US7001909B2/en not_active Expired - Fee Related
-
2004
- 2004-01-16 KR KR1020057013173A patent/KR20050092421A/ko not_active Ceased
- 2004-01-16 AU AU2004207764A patent/AU2004207764C1/en not_active Ceased
- 2004-01-16 WO PCT/US2004/001096 patent/WO2004067506A2/en not_active Ceased
- 2004-01-16 JP JP2006502846A patent/JP2006516036A/ja active Pending
- 2004-01-16 EP EP04702915A patent/EP1583760A2/en not_active Withdrawn
- 2004-01-16 NZ NZ541307A patent/NZ541307A/en unknown
- 2004-01-16 CA CA002513641A patent/CA2513641A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7001909B2 (en) | 2006-02-21 |
| NZ541307A (en) | 2008-11-28 |
| WO2004067506A2 (en) | 2004-08-12 |
| WO2004067506A3 (en) | 2004-11-04 |
| JP2006516036A (ja) | 2006-06-15 |
| CA2513641A1 (en) | 2004-08-12 |
| AU2004207764B2 (en) | 2009-03-26 |
| AU2004207764C1 (en) | 2009-10-22 |
| US20030176447A1 (en) | 2003-09-18 |
| EP1583760A2 (en) | 2005-10-12 |
| AU2004207764A1 (en) | 2004-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100919141B1 (ko) | 치환 피페라진 화합물 및 그의 지방산 산화 저해제로서의용도 | |
| US6200998B1 (en) | Arylthiazolidinedione derivitives | |
| AU2004207764C1 (en) | Substituted heterocyclic compounds | |
| US7056924B2 (en) | Substituted heterocyclic compounds | |
| US7026321B2 (en) | Substituted heterocyclic compounds | |
| AU2003300827B2 (en) | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | |
| AU2002322527C1 (en) | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | |
| AU2002322527A1 (en) | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | |
| HK1064374B (en) | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | |
| HK1083492B (en) | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | |
| KR20070051305A (ko) | 치환된 피페라진 화합물 및 지방산 산화 저해제로서의 이의용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20050715 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20081103 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20101028 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20101230 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20101028 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |